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ABSTRACT OF DISSERTATION 
 
 
ILLUMINATE THE PATHWAY OF MEMBRANE PROTEIN ASSOCIATION AND 
DEGRADATION 
 
Escherichia coli transporter protein AcrB and its homologues are the inner 
membrane components of the Resistance-Nodulation-Division (RND) family efflux pumps 
in Gram-negative bacteria. It is well accepted that soluble proteins are only marginally 
stable, but such insight is missing for membrane proteins. The lack of stability data, 
including thermodynamic stability and oligomer association affinity is a result of intrinsic 
difficulties in working with membrane proteins. In addition, the degradation of soluble 
proteins in E. coli has been extensively studied whereas the degradation process of 
membrane proteins remains unclear.  A focus of my thesis is the validation and 
development of methods used to measure the thermo- and oligomeric- stability of 
membrane proteins. I investigated the mechanism of a popular thermal-stability assay 
developed specifically for the study of membrane proteins uses a thiol-specific probe, 7-
diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin (CPM). I found that, contrary to 
current understanding, the presence of a sulfhydryl group was not a prerequisite for the 
CPM thermal stability assay. The observed fluorescence increase is likely caused by 
binding of the fluorophore to hydrophobic patches exposed upon protein unfolding. I then 
applied these methods in the study of three projects. In the first project, I investigated how 
suppressor mutations restore the function of AcrBP223G, in which the Pro223 to Gly 
mutation compromised the function of AcrB via disrupting AcrB trimerization. The results 
suggested that the function loss resulted from compromised AcrB trimerization could be 
restored through various mechanisms involving the compensation of trimer stability and 
substrate binding. In the second project, I created two AcrB fusion proteins, with C-
terminal yellow fluorescence protein (YFP) and cyan fluorescence protein (CFP), 
respectively. YFP and CFP form a fluorescence resonance energy transfer (FRET) pair. 
Using this pair of fusion proteins, I studied AcrB assembly both in detergent micelles and 
in lipid bilayers. A positive cooperativity was observed in kinetic studies of association of 
AcrB trimer. Reconstitution experiment revealed that the association showed a higher 
FRET efficiency and faster association rate in liposome than in DDM. In the last project, I 
developed a fluorescence method to study the degradation of AcrB-ssrA by the ClpXP 
system. Comparing to the degradation of GFP-ssrA, degradation of AcrB-CFP-ssrA 
showed a lower maximum velocity and tighter binding to the enzymes with a positive 
 
 
cooperativity. 
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Chapter Ⅰ. Introduction 
 
1.1 A brief introduction of multidrug resistance  
Penicillin, a wonder discovered by Alexander Fleming in 1928, saved thousands of lives in 
World War Ⅱ.However, the good situation didn’t last for long. Twelve years later, even 
before the massive production of penicillin as a therapeutic, researchers discovered 
bacterial penicillinases (also called β-lactamase) which provides resistance to β-Lactam 
antibiotics.1 Later on, researchers found some bacteria are resistant to more than one kind 
of antibiotics and named them multiple antibiotic resistance or multidrug resistance (MDR) 
bacteria. With more and more cases of MDR infection reported, soon MDR became a 
severe public health threat all over the world.2 In Europe, close to 25,000 people died from 
MDR every year. In the United States, the effect of MDR is more severe, with over 63,000 
people died from MDR every year.3 In contrast to the fast growth of drug resistant 
infections, the development of new antibiotics is lagging behind. Thus, more efforts are 
needed to thoroughly understand the mechanism of MDR in order to find effective ways 
to treat infections caused by drug resistant pathogen.  
 
There are five main mechanisms that lead to bacterial drug resistance (Figure 1.1): (1) 
inactivation or detoxification of antibiotics by enzyme4 (for instance, penicillinases 
catalyze the hydrolysis of penicillin to reduce the effective concentration of the drug in 
bacteria), 5 (2) reduced uptake into cells or active efflux from cells (e.g. Drug efflux pumps 
such as the AcrAB-TolC complex expel a broad range of antibiotics to reduce the cellular 
concentration to a sub-toxic level), 6 (3) modification of targets to reduce binding with the 
2 
 
antibiotics (e.g. The affinity with antibiotics is reduced by mutations of the genomic copy 
of the target enzyme or acquisition of a new plasmid-borne enzyme to compensate for the 
loss of function),7 (4) reduced uptake of the drug caused by the change of the expression 
level or structure of cell wall proteins,8 and (5) metabolic bypass of antibiotics (e.g. the 
resistance to glycopeptide antibiotic vancomycin).9  
 
Figure 1.1 Some examples about the mechanism of drug efflux pumps. 
 
Based on amino acid sequence, energy sources, and substrates, bacterial efflux pumps 
could be classified into five families: the major facilitator superfamily (MFS), the 
resistance-nodulation-division (RND) family, the ATP-binding cassette (ABC) superfamily, 
the small multidrug resistance (SMR) family, and the multidrug and toxic compound 
extrusion (MATE) family (Figure 1.2).10 
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Figure 1.2 Families of MDR efflux pumps. 
 
MFS family exists in almost all kingdoms of life importing or exporting substrates which 
include simple sugars, inositols, drugs, amino acids, oligosaccharides, nucleosides, esters 
and a large variety of organic and inorganic ions coupled with the transport of proton as 
energy source.11; 12 All of the MFS transporters share a common characteristic structure 
known as the MFS fold, which contains 12 transmembrane helices and two domains (N-
domain and C-domain).13 Efflux pumps of RND family, widely found in Gram-negative 
bacteria, play key roles in providing multidrug resistance. Using proton motive force as the 
energy source, RND efflux pumps export a lot of substrates directly to external medium. 
There are three components in the efflux pumps: inner membrane transporter, adaptor 
protein, and outer membrane channel.14 ABC transporters are ubiquitously present in all 
prokaryotes, fungi, plant, and animals. It’s worth noting that the ABC superfamily transport 
substrates using ATP hydrolysis as the energy source, which is different from the other four 
superfamilies. In the human genome, there are 49 ABC genes whose mutation cause severe 
hereditary diseases. The transporters are also involved in translocation of drugs and 
metabolites, which is related to cancer therapy.15 Composed of four transmembrane α-
helices of 100-140 amino acids in length, the bacterial SMR proteins need to oligomerize 
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for substrate extrusion. The SMR pumps export peptides, complex carbohydrates, sugars, 
drugs, and metals in various ionic states driven by the proton motive force (PMF) 
mechanism.16; 17 The MATE family, the most recently identified transporter family, exists 
in all three kingdoms: Eukarya, Archaea, and Eubacteria. Prokaryotic MATE proteins 
utilize H+ or Na+ electrochemical gradient as energy source while eukaryotic MATE 
proteins utilize only H+ gradient.18; 19  
 
MDR related diseases, including multidrug resistant tuberculosis (MDR-TB) and 
infections caused by multidrug resistant Acinetobacter baumannii, have threatened 
thousands of people. MDR-TB is caused by Mycobacterium tuberculosis which is resistant 
to two most potent first-line anti-tuberculosis drugs — isoniazid and rifampicin.20 In 2015, 
around 480,000 cases of MDR-TB were reported globally, among which about 9.5% cases 
were estimated to be extensively drug resistant tuberculosis (XDR-TB) with additional 
resistance to fluoroquinolones and second-line injectable drugs. MDR-TB has a mortality 
rate of up to 80%. A best estimate from some reports in 2012 showed that there were 
150,000 deaths out of 450,000 patients globally.21 To treat MDR-TB, a recommended 
regimen is the combination of at least four antituberlosis drugs to Mycobacterium 
tuberculosis. Multidrug resistant Acinetobacter baumannii, resistant to a lot of antibiotics 
including aminopenicillins, ureidopenicillins, cephalosporins, cephamycins, 
aminoglycosides, chloramphenicol, and tetracyclines, has been found in many hospitals 
since 1980.22 As a rapidly emerging pathogen in healthcare settings, A. baumannii causes 
infections including pneumonia, bacteremia, meningitis, urinary tract and wound 
infections.23 An estimated mortality rate of 30% – 75% was reported for nosocomial 
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pneumonia caused by A. baumannii.24 Up to now, two methods have been used to treat 
infections caused by multidrug resistant A. baumannii: 1) monotherapy with using 
carbapenem or ampicillin or sulbactam, and 2) combined therapy with two or more drugs.25 
   
1.2 The resistance nodulation cell division (RND) family 
Unlike the other four families of multidrug resistance efflux pumps, RND efflux pumps are 
only present in Gram-negative bacteria. In the early 1990s, RND pumps were first 
identified in E. coli and Pseudomonas aeruginosa by two different research groups 
respectively.26 Functioning as a tripartite complex, these pumps are composed of the 
transporter protein (RND: the inner membrane component), membrane fusion protein 
(MFP: the periplasmic component), and the outer membrane protein channel (OMP: the 
outer membrane protein). All these three proteins are essential for drug translocation; any 
defect in any one component can cause the entire complex totally non-functional.14 These 
three proteins form a continuous channel across the bacterial envelope which ensures 
substrate molecules (likely captured from the outer leaflet of the inner membrane bilayer) 
to be exported directly across the periplasm and the outer membrane. Yet, it is still not clear 
whether the periplasm or inner membrane is the predominant location of substrate capture, 
and how and to what extent the substrates may be captured from the cytosol.27    
 
To date, over 30 types of RND pumps have been identified. Among them, MexAB-OprM, 
MexCD-OprJ, MexEF-OprN, and MexXY-OprM from P. aeruginosa, and AcrAB-TolC, 
AcrAD-TolC, and AcrEF-TolC from E. coli have been intensively studied.28-31 P. 
aeruginosa, an opportunistic pathogen, is notable for high level resistance to antimicrobial 
6 
 
agents due to the existence of Mex efflux pumps MexAB-OprM and MexXY-OprM.32 In 
addition to antibiotics, Mex efflux pumps also export organic solvents, biocides, dyes, and 
cell signaling molecules. Single crystal structures of MexA, MexB and OprM have been 
obtained through high-resolution X-ray crystallography (Figure 1.3). OprM, the trimeric 
protein channel, consists of a 4-nm-long transmembrane domain with 12 strands that form 
a β-barrel and a 10-nm-long periplasmic domain with 12 α-helices and a mixed α/β 
equatorial domain. Trimeric transporter MexB contains a 12 transmembrane α-helices 
domain in each protomer and a large periplasmic part including a porter domain and a 
funnel domain. MexA consists of four consecutive domains: membrane proximal, β-barrel, 
lipoyl and α-helical hairpin domains. MexA is anchored to the inner membrane via 
palmitoylation of an N-terminal cysteine residue.32  
 
Figure 1.3 Crystal structures of OprM (A), MexA (B), and MexB (C). Protein Data Bank 
(PDB) ID are 4Y1K for OprM, 1VF7 for MexA, 3W9I for MexB, respectively. 
 
Although the crystal structures of MexA, MexB and OprM have been individually obtained, 
the assembly mechanism of the tripartite system is particularly challenging because the 
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complex span across two different membranes and periplasm. With the development of 
advanced electro tomography technique such as cryo-EM, complicated protein structures, 
particularly for complex like MexAB-OprM (Figure 1.4, A) and AcrAB-TolC (Figure 1.4, 
C), have been resolved. For MexAB-OprM, a sandwich-shape with an intermembrane 
distance of 21 nm was observed in lipid nanodisc system where MexA did not directly 
contact to OprM.31 For AcrAB-TolC, the intense debate about whether AcrB directly 
contacts TolC came to an end after the whole structure of AcrAB-TolC was obtained from 
cryo-EM in 2014. There was no interaction between AcrB and TolC observed from their 
result.33; 34  
  
 
Figure 1.4 Structure models showing complex MexAB-OprM and AcrAB-TolC. A. 
Isocontours of MexB-ND and OprM-ND (red) overlaid on isocontours of tripartite 
complex. B. Assembly model of MexAB-OprM in nanodisc.31 C. 5.9 Å resolution cryo-
EM asymmetric structure of the AcrABZ-TolC pump in presence of puromycin.35 
Reprinted with permission from Rightslink® Service and Elife Sites. 
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1.3 Efflux pump complex AcrAB-TolC 
The multidrug efflux pump AcrAB-TolC (Figure 1.4, C), a member of the RND family 
and one of the most extensively studied systems, is a tripartite efflux transporter.36 ‘Acr’ is 
the acronym of “acriflavin resistance”, one of the first compounds that the AcrAB-TolC 
system is found to transport, and TolC refers to “tolerance to colicin”. Like other members 
in the RND family, AcrAB-TolC complex comprises three components: the proton-driven 
transporter protein AcrB, the membrane fusion protein AcrA, and the outer membrane 
channel TolC.37  
 
In 2006, Mikolosko and coworkers determined the crystal structure of AcrA.38 According 
to the crystal structure they obtained, AcrA is a dyad symmetric dimer of dimers which are 
divided into α helical hairpin domains, β-barrel domains, and lipoyl domains (Figure 1.5). 
As a membrane fusion protein, the main function of AcrA is stabilizing the connection 
between AcrB and TolC through the interaction of apices of their periplasmic domain.39 
Previous studies suggest that the α helical hairpin domain is likely to interact with the 
channel protein TolC while the β-barrel domain contacts with the transporter protein AcrB, 
so that the drug efflux pump works to pump out the antibiotics.40-42 Unlike AcrB and TolC 
functioning as trimers, AcrA acts as a hexamer in the AcrAB-TolC complex according to a 
study by Xu.43  
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Figure 1.5 Structure of AcrA. A: side view. Ribbon representation of two apparent dimers 
in one subunit. B: top view. The structures were generated using Pymol (PDB ID: 2F1M).38 
 
The crystal structure of TolC was determined by Koronakis et al. in 2000 (Figure 1.6).44 
According to the crystal structure obtained, the trimeric channel TolC comprises three parts: 
a β-barrel domain, an α helical domain (periplasmic domain), and a mixed α/ β domain 
(equatorial domain) in each protomer.44 The overall length of TolC is about 140 Å with 40 
Å in the β-barrel domain mainly composed of β strands, and 100 Å in the periplasmic 
domain mainly composed of α helices. The β-barrel domain in the outer membrane and the 
periplasmic domain in periplasm form a continuous channel with an internal diameter of 
35 Å, which is one of the largest known protein structure .44 E. coli strains deficient in TolC 
are more sensitive to a wide variety of chemicals in the environment (e.g. detergents, drugs, 
bile salts, and organic solvents) than wild type strains. Besides exporting small molecules 
of chemical compounds, TolC is also involved in the transport of large molecules such as 
proteins.45  
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Figure 1.6 The overall architecture of TolC. A: side view. B: top view. C: bottom view. The 
ribbon structure was created using Pymol.50 (PDB code: 1EK9)  
 
The RND transporter protein AcrB, responsible for the drug recognition and energy 
transduction, resides in the inner membrane of bacteria cells. The crystal structure of AcrB 
was first described by Murakami et al.  in 2002.46 AcrB, in a jellyfish shape, is a trimeric 
protein containing 1049 amino acids in each protomer. It is composed of three domains: 
transmembrane domain, pore domain, and TolC docking domain (Figure 1.7, A). Driven 
by the proton motive force, a broad range of substrates are recognized and pumped out by 
AcrB. These substrates include acriflavin, rhodamine 6G, berberine, tetraphenyl-
phosphonium, ethidium, ciprofloxacin, erythromycin, acridine, etc.47 Exchange of AcrB 
and AcrD periplasmic loops altered the substrate preference of the proteins, suggesting that 
residues dictating substrate specificity reside in the porter domain.  A deep binding pocket 
was later defined through additional mutational and crystallographic studies. While 
initially the three protomers in a trimer were considered to adopt the same conformation, 
two papers published by Pos group48 and Yamaguchi group49 in 2006 showed that in an 
AcrB trimer, each monomer adopts a different conformation. They speculated that each 
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conformation represents a different state during the transport cycle, loose (L), open (O) and 
tight (T), which leads to a completely new model about the mechanism of drug 
translocation. Using Bodipy-FL-maleimide labeling, Nikaido and coworkers elucidated the 
entire substrate translocation pathway in vivo. Their observations showed that the 
substrates are captured in the lower cleft region of AcrB, then translocated to binding 
pocket and transported to the AcrB funnel through the gate, and finally exported by TolC.50 
Later, the substrates were divided into two groups depending on where they interact: 
groove binder and cave binder. Groove binders are defined as the substrates found within 
the narrow groove in the part of the binding pocket far away from the membrane surface, 
whereas cave binders are defined as other substrates bound with a larger cave area close to 
the membrane surface.51; 52  
 
Figure 1.7 Crystal structure of AcrB. A. Side view of ribbon representation, three protomers 
are colored cyan, pink and green, respectively. From top to bottom, the three domains, TolC 
docking domain (about 30 Å), pore domain (about 40 Å) and transmembrane domain 
(about 50 Å) are shown. B. Top view. C. Bottom view. The structures are generated using 
Pymol (PDB ID: 2GIF).46  
 
Individual crystal structures of AcrA, AcrB and TolC have been resolved for more than ten 
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years, which shed light on the substrate recognition and binding. However, how the 
components are assembled into a functional pump and the stoichiometry was not clear until 
2014 when the first AcrABZ-TolC structure was obtained through cryo-EM (Figure 1.8).34 
With the help of linkers between each component, AcrA-AcrZ and AcrA-AcrB fusions with 
endogenous TolC were co-expressed and purified. The complex remained intact after 
purification, making observation of the assembled structure possible. Three important 
findings rose from the final model which agreed well with the density envelope. Firstly, 
there is no direct interaction between TolC and AcrB in the pump, which is inconsistent 
with the model hypothesized by Martyn F. Symmons et al.53 Secondly, the stoichiometry 
for AcrB: AcrA: TolC is 3:6:3. Thirdly, a resting state of TolC was observed.  
 
Figure 1.8 A. A pseudo-atomic model of the drug efflux pump AcrAB-TolC. B. Modeled 
interactions of the efflux pump components.34 Reprinted with permission from Rightslink® 
Service.  
 
Another series of cryo-EM structures of AcrAB-TolC in resting and drug transporting states 
were then reported (Figure 1.9).35 In resting state, TolC is in a closed conformational state 
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as shown in Figure 1.9 A. When the substrates bind to AcrB, AcrB monomers circulate the 
three conformational states — loose (L), tight (T), and open (O),54 then TolC channel opens 
to pump out the substrates transported from AcrB. In this process, AcrB monomers rotate 
using proton motive force as energy source. The pump inhibitor MBX3132 binds to AcrB 
tightly which locks the pump in a more homogeneous conformation in which all AcrB 
subunits are shown in the same (TTT) conformation.35  
 
Figure 1.9 2D average structures showing the pump states of resting (A), in presence of 
puromycin (B) and pump inhibitor MBX3132 (C).35 
 
To control the spread of antibiotic resistance, discovering and screening efflux pump 
inhibitors becomes urgent. To date, several efflux pump inhibitors have been reported, 
including D13-9001, MC207110 (phenylalanylarginine-β-naphthylamide, PAβN), and 
MBX2319 (Figure 1.10).55 All inhibitors reported act under similar mechanism. MBX2319 
binds tightly to the lower part of the distal pocket in the AcrB protomer, interacting with 
phenylalanines lining the hydrophobic trap, where D13-9001 also binds. However, PAβN 
appears to bind to a different area of the distal pocket in the protomer. Besides investigating 
how inhibitors work on the transporter AcrB, researchers also focus on developing efflux 
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pump inhibitors of other components. Narges Abdali et al.55 screened efflux pump inhibitor 
candidates and found that NSC60339 showing positive inhibition effect bound to different 
sites of AcrA which could be used as a potential therapeutic target.   
 
Figure 1.10 RND efflux pump inhibitors developed, MBX2319, D13-9001 and PaβN for 
AcrB, and NSC 60339 for AcrA.56; 55  
 
1.4 Fluorescent protein and FRET. 
Fluorescence is defined as a phenomenon that a substance absorbs light or other radiation 
source and emits light with a different wavelength. The main principle of fluorescence is 
that electrons of fluorophore excited by light or other radiation source go to higher singlet 
states and then relax to ground state by emitting photons. Fluorescence was firstly reported 
by a Spanish physician and botanist, Nicholάs Monardes in 1565.57 He reported the 
observation of fluorescence from a wood called lignum nephriticum which was used as 
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medicine by Aztecs (Figure 1.11). In 1819, Edward D. Clark found some crystals of fluorite 
reflected light and displayed a deep sapphire blue color from Weardale, Durham, England. 
The word “fluorescence” was firstly used by George Gabriel Stokes, physicist and 
professor of mathematics at Cambridge in his famous paper entitled “On the Refrangibility 
of Light” in 1952. The Stokes’ shift which describes the difference between maxima of 
excitation and emission peaks in fluorescence spectrum was also named after him.  
 
Figure 1.11 A. Absorption and fluorescence colors of an infusion of Lignum nephriticum 
under day light. B. The solution obtained from infusion of the wood. Taken from Safford, 
W. E. (1915).58 
 
Although the phenomenon of Förster resonance energy transfer or Fluorescence resonance 
energy transfer (FRET) had been observed before the 20th century, the first quantum 
mechanical theories of FRET was developed by Heisenberg, Schrödinger and Dirac in 
1925.59 As shown in Figure 1.12, FRET takes place between two fluorophores that are close 
to each other, resulting in the energy transference from a “donor” fluorophore to an 
“acceptor” fluorophore through non-radiative dipole-dipole coupling.60 In this process, 
electrons of donor excited by absorbing photons with high energy go from electronic 
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ground state S0 to electronic singlet state S1, and then the electrons from different 
vibrational levels of S1 state relax to lowest vibrational level, followed by transition to S0 
state. Finally, the acceptor which absorbs the energy from the donor is excited to S1 state, 
and emits light at a different wavelength from the donor fluorophore when it relaxes from 
S1 to S0.61 Because FRET occurs only when two fluorophores are close enough, 
measurement of FRET can be used to determine the relative distance between the two 
molecules. Based on this principle, the applications of FRET have been extended in many 
disciplines including biology and chemistry with the development of techniques and 
fluorescent proteins. FRET has many advantages, for instance, it is highly sensitive due to 
the use of fluorescence spectrometer; it can be used in in vivo studies, especially suitable 
for live cell imaging; and sometimes it can be developed into assays for high-throughput 
screening.62 FRET is especially useful for studies involving membrane proteins, since it is 
compatible with the lipid bilayer environment. There are mainly two FRET strategies that 
can be used in membrane protein studies — donor quenching and acceptor sensitization: 
donor quenching relies on the monitor of quenching of the donor fluorescence in the 
presence of acceptor, whereas acceptor sensitization monitors the fluorescence signal 
increase of acceptor when the donor is excited.63  
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Figure 1.12 Jablonski diagram of FRET with typical timescales indicated. 
 
Green fluorescent protein (GFP) was discovered from Aequorea jellyfish (Figure 1.13, A) 
by Shimomura et al. (1962) as a companion protein to aequorin.64 Soon the same group 
published the emission spectrum of GFP with an emission peak at 508nm.65 Later, 
researchers crystalized GFP and analyzed its structure, discovered that the chromophore 
was formed from residue 65-67 (Ser-Tyr-Gly) in the native protein.66 High resolution 
crystal structure was resolved in 1996 by Ormö et al. (PDB ID 1EMA) (Figure 1.13, B).67 
The crystal structure showed the dimeric wild type GFP (WT-GFP) is cylinder-shaped with 
an 11-stranded β-barrel threaded by an α-helix inside. The chromophore attached to the α-
helix is perfectly buried in the center of the cylinder called β-can.68 WT-GFP folds 
efficiently when expressed at or below room temperature. However, such folding efficiency 
declines drastically when the temperature is higher than the room temperature. WT-GFP 
has some undesirable properties including a lag in the development of fluorescence, poor 
expression in other host cells, and low fluorescent intensity when excited by blue light. 
Compared with other reporters such as β-galactosidase used in mammalian cells, the 
sensitivity of WT-GFP is lower. So an enhanced GFP version “EGFP” (where GFP has two 
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mutations—Phe64 to Leu and Ser65 to Thr) was developed by Zhang et al. in 1996.69 A 
1.5 Å crystal structure of EGFP was obtained in 2012, showing that the side chain in the 
central chromophore is smaller due to the mutation F64Land β-strand 2 is packed tighter 
with the core.  S65T disrupts the hydrogen bonding with Glu222, removing the electrostatic 
clash with an anionic form of ground state of chromophore. These changes give EGFP 
better excitation characteristics and higher folding efficiency at 37 oC.70   
 
Figure 1.13 Aequorea jellyfish (A). Green fluorescent protein (GFP, B), PDB ID: 1EMA.  
 
With the application of FRET techniques and wide use of fluorescent proteins in studies of 
biochemical processes, more and more GFP derivatives such as CFP, YFP, OFP, RFP, and 
their enhanced versions have been developed (Table 1.1). The purpose of the mutations is 
a) to make the protein fold faster,  b) to improve the brightness and c) increase the quantum 
yield by creating or removing some interactions in chromophore, or d) to shift the 
excitation and emission wavelengths so that the fluorescent proteins can suit the studies 
better.71; 72 With fluorescent proteins having different colors, five primary FRET 
approaches have been used in research:73 1) sensitized emission, or two color ratio imaging 
with controls (e.g. spatiotemporal dynamics of CaMKII activation in individual dendritic 
spines during long-term potentiation was monitored using FRET between mEGFP and 
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REACh, a green fluorescent protein as donor and a yellow fluorescent protein as 
acceptor),74 2) acceptor photo-bleaching where the FRET efficiency can be calculated by 
subtracting the donor intensity in presence or absence of the acceptor, 3) fluorescence 
lifetime imaging microscopy (FLIM), a method takes advantage of the fact that the rate of 
fluorescence exponential decay is sensitive to environmental change that quenches the 
fluorescence and thus the amount of quenching of donor fluorescence could be indicated 
via the shortening of the fluorescence decay time, 4) spectral imaging, where the 
fluorescence spectra for both donor and acceptor are collected to determine the level of 
FRET, and 5) polarization anisotropy imaging, a method well-suited for high-content 
screening with a high signal-to-noise ratio based on the measurement of fluorescence 
polarization.  
 
Table 1.1 Representatives of GFP variants and the mutations relative to WT-GFP.71; 72 
GFP variant Mutations relative to WT-GFP 
EGFP F64L, S65T 
Emerald F64L, S65T, S72A, N149K, M153T, I167T 
EYFP S65G, V68L, S72A, T203Y 
mYFP S65G, V68L, Q69K, S72A, T203Y, 
A206K 
Citrine S65G, V68L, Q69M, S72A, T203Y 
mCitrine S65G, V68L, Q69M, S72A, T203Y, 
A206K 
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Table 1.1 Representatives of GFP variants and the mutations relative to WT-GFP 
(continued).71; 72 
Venus F46L, F64L, S65G, V68L, S72A, M153T, 
V163A, S175G, T203Y 
YPet F46L, I47L, F64L, S65G, S72A, M153T, 
V163A, S175G, T203Y, S208F, V224L, 
H231E, D234N 
ECFP F64L, S65T, Y66W, N149I, M153T, 
V163A 
mCFP F64L, S65T, Y66W, N149I, M153T, 
V163A, A206K 
Cerulean F64L, S65T, Y66W, S72A, Y145A, 
H148D, N149I, M153T, V163A 
CyPet T9G, V11I, D19E, F64L, S65T, Y66W, 
A87V, N149I, M153T, V163A, I167A, 
E172T, L194I 
Clover S30R, Y39N, S65G, Q69A, N105T, 
Y145F, M153T, V163A, I171V and T203H 
EBFP F64L, S65T, Y66H, Y145F 
T-Sapphire Q69M, C70V, S72A, Y145F, V163A, 
S175G, T203I 
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1.5 AAA+ proteases   
AAA+ proteases, with at least one protein component which belongs to ATPase Associated 
with diverse cellular Activities, are generally comprised of ClpXP, ClpAP, ClpCP, Lon, 
FtsH, HslUV, PAN/20S, the 26S proteasome, and their homologues.75 The protease 
degrading the misfolded protein substrate is a complicated biological process: it usually 
starts with the AAA+ rings binding the exposed peptide segment in the axial pore, followed 
by the conformation changes of the rings driven by ATP hydrolysis, and ends with the 
protein unfolding and translocation into the degradation machine where unfolded peptides 
are degraded. Different families of the proteases have different architectures. Lon and FtsH 
families only contain one component, that is, hexamers of six identical subunits with a 
protease domain and an ATP binding domain.76 Other families such as ClpXP, ClpAP, and 
HslUV include two components with different structures and assemblies: ClpX, ClpA, and 
HslU protein form a hexameric AAA+ rings with six identical subunits, whereas ClpP and 
HslV protease form a double-ring structure that consists of 12 and 14 subunits, 
respectively.77 More complicated structures were observed in the PAN/20S protease and 
26S proteasome which include an AAA+ ring and α7β7β7α7 compartmental protease as 
their basic architectural features.78; 79  
 
ClpXP is a well-studied degradation system among all the AAA+ proteases. To recognize 
and degrade the protein substrates, a recognition/degradation tag (also known as degron) 
is necessary. In E.coli, ssrA tag with an 11-amino acid sequence “AANDENYALAA” 
serves as the degradation tag. The aminoacylated-ssrA RNA (tmRNA) is recruited to 
ribosomal A site when the ribosome stalls on an incomplete or untranslatable message. The 
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nascent chain encoding original gene is replaced by tmRNA with gene encoding ssrA tag 
translated by ribosome.80 Substrates bearing new synthesized ssrA tag is recognized by the 
SspB adaptor and ClpX. The SspB adaptor binds to the first seven amino acid “AANDENY” 
of the tag, tethering the substrate to ClpXP protease, while ClpX recognizes the last three 
amino acid “LAA” and unfolds the protein substrate. Finally, denatured polypeptides are 
translocated and degraded into smaller pieces by ClpP.81  
 
ClpX is a hexameric AAA+ machine which uses ATP as the energy source to unfold and 
translocate denatured polypeptides to ClpP. The hexamer of ClpX is asymmetric in both 
nucleotide-free and nucleotide-bound structures (Figure 1.14, A). Each monomer has two 
domains, a large domain (residues 61-314) and a small domain (residues 320-416) with a 
linker between the two domains (residues 315-319). The asymmetry of ClpX is generated 
by changes in the interfaces between each subunit or between the two domains when the 
nucleotide-free and nucleotide-bound structures switch.77 ClpX6 has six ATP/ADP binding 
sites that locate at the interface between the large and small domains from adjacent 
subunits.78 Interestingly, only four out of the six binding sites could actually be used to 
bind with ATP/ADP. This phenomenon could be explained by the crystal structure of ClpX6 
obtained by Dr. Sauer’s lab. That is, there are two types of subunit conformations (named 
type 1 and type 2) in the closed ClpX hexamer, which has a 1-1-2-1-1-2 pattern (Figure 
1.14, B). Two ATP/ADP binding sites are occupied by the small domain in type 2 subunit, 
so only four out of six binding sites can bind with ATP/ADP.  
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Figure 1.14 A. Crystal structures of ClpX (PDB ID: 3HTE). B. Model shown type 1 and 
type 2 subunits and ATP/ADP binding sites (red stars).  
 
ClpP, a tetradecamer with two rings (each contains seven subunits), is a serine-peptidase 
cleaving peptides after hydrophobic residues.82 Ser 97, His 122, and Asp 171 are identified 
as three components of the catalytic triad of ClpP.83 ClpP alone only cleaves peptides of 
fewer than six residues while it degrades longer peptides with the help of ATPase such as 
ClpX and ClpA. Producing degradation fragments of 7 to 10 residues, the degradation does 
not show any clear sequence specificity.84; 85 The crystal structure of ClpP which has a 
cylindrical shape of 90 Å both in height and diameter shows that the active sites are in a 
central chamber (Figure 1.15, A). Theoretically, the central chamber could accommodate 
several hundred unfolded polypeptide residues. The cleavage of polypeptides is efficient 
due to two factors: the high local concentration of active sites (about 350 mM) and the long 
distance between two adjacent active sites in ClpP chamber (around 25 Å, which could 
span across 8 residues). Therefore, a polypeptide could simultaneously bind to multiple 
active sites, increasing the efficiency of degradation. With such a mechanism, the cleavage 
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rate of ClpP reported is about 10,000 min-1.86; 87 When the unfolded polypeptides are 
translocated into ClpP14, a conformational switch between a compressed state (i.e.  closed 
active sites/open equatorial pores; Figure 1.15, B) and an extended state (i.e. open active 
sites/closed equatorial pores) give researchers insight into how ClpP cleaves the protein 
substrates and how degradation products are exited.88  
 
Figure 1.15 A. Crystal structure of ClpP, one subunit (PDB ID: 3QWD). B. Structure switch 
between closed state and extended state.   
SspB (stringent starvation protein B) is a dimeric delivery/adaptor protein which binds 
specifically to the first seven residues of ssrA tag “Ala1 Ala2 Asn3 Asp4 Glu5 Asn6 Tyr7”, 
enhancing the degradation of ssrA-tagged protein by ClpXP and inhibiting the degradation 
by ClpAP.89; 90 Consisting of a single α-helix and a β-sandwich formed by stacking of a-β 
sheet (β2- β1- β6- β7) onto another β-sheet (β5- β4- β3), the overall dimension of SspB is 
around 63×33×22 Å (Figure 1.16, A). An important role of SspB is tight binding of the 
ssrA tag in the hydrophobic pocket, mainly the side chain of Ala1 and Ala2. ClpA also 
recognizes Ala1 and Ala2 and thus cannot degrade SspB bound substrate. Another critical 
residue in the ssrA tag is Tyr7, the aromatic ring of which is sandwiched between several 
SspB side chains.89 From the model of SspB delivery system, two ssrA tagged protein 
substrates could be bounded simultaneously to one SspB dimer and delivered to the central 
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pore of ClpX due to the flexible binding domain (Figure 1.16, B).90  
 
Figure 1.16 A. Crystal structures of SspB monomer. (PDB ID: 1OX8) B. Model for the 
SspB-Mediated of an ssrA-tagged protein to ClpX. The pictures belong to Cell Press.90   
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Chapter Ⅱ. Probing Membrane Protein Stability Using CPM Fluorescence - a 
Mechanistic Study 
 
Part of this chapter are taken from “CYSTEINE RESIDUE IS NOT ESSENTIAL FOR 
CPM PROTEIN THERMAL-STABILITY ASSAY”, 2015, Analytical and bioanalytical 
chemistry. 407, 3683-3691.134 
 
2.1 Introduction 
Stability measurement of membrane proteins is a challenging task because of the scarcity 
of high-resolution protein structures and the lack of proper techniques.91; 92 Methods 
developed to reversibly unfold and refold soluble proteins are not always useful for 
membrane proteins.93 A variety of techniques have been developed or adapted to probe 
membrane protein unfolding, including analytical ultracentrifugation, FRET, disulfide 
cross-linking, and chemical and thermal denaturation.92  
 
For soluble proteins, CD spectroscopy has been the method of choice to monitor protein 
thermal denaturation.94 The ellipticity at a specific wavelength, usually a signature of a 
specific secondary structure type, is recorded upon heating. The unfolding of the protein 
leads to a reduction of the secondary structure content, and thus a reduction of ellipticity.  
But for α-helical membrane proteins, it is well-established that the transmembrane helices 
are highly stable and do not completely unfold even at temperature close to the boiling 
point.95 Therefore, in many cases a clear transition point cannot be observed. In addition, 
the properness of using CD to monitor α-helical membrane protein unfolding is 
questionable, because the unfolded state of the protein could be a bundle of loosely 
associated helices. Therefore, the protein could have already unfolded with little change of 
the helical content being observed.  
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In a popular method used to investigate the thermal stability of membrane proteins, 
unfolding was monitored via the exposure of Cys residues and the subsequent reaction with 
(N-[4-(7-diethylamino-4-methyl-3-coumarinyl) phenyl] maleimide (CPM). CPM is a thiol-
specific probe whose fluorescence emission intensity increased drastically upon the 
reaction with a sulfhydryl group in a protein.96 The formation of a thioether and the 
concurrent attachment to the protein is revealed by a surge of fluorescence emission at 463 
nm (excited at 387 nm). The presence of reactive free sulfhydryl groups in the protein 
structure is considered a prerequisite. Since free Cys residues are usually found in the 
hydrophobic core of a folded protein structure, the unfolding of the protein and subsequent 
exposure of the Cys is expected to greatly accelerate the thiol-specific reaction. The 
sensitivity and versatility of this method has made it a very convenient technique, which 
has been used to probe the stability of many membrane proteins.97; 98  
 
Table 2.1 Melting temperature of membrane proteins determined using the CPM-thermal 
denaturation method. 
Full name Buffer condition Tm (oC) Reference 
Fatty acid amide hydrolase 
(FAAH) 
400 mM NaCl, 10% glycerol, 20 
mM HEPES (pH 7.5), 0.1% 
(w/v) DDM 
46 96 
FAAH with inhibitor 
MAFP 
400 mM NaCl, 10% glycerol, 20 
mM HEPES (pH 7.5), 0.1% 
(w/v) DDM 
58 96 
Human apelin receptor 
(APJ receptor) 
400 mM NaCl, 10% glycerol, 20 
mM HEPES (pH 7.5), 0.1% 
(w/v) DDM 
44.7-
44.9 
96 
Rce1 20 mM MES, pH 6.5, 200 mM 
NaCl, 0.029% (w/v) UDM and 
0.86% (w/v) OG 
48.2 99 
Connexin 26/ ATP binding 
cassette transporter MsbA 
20 mM Tris (pH 8.0) and 1 M 
NaCl. 1% (w/v) detergent 
(DDM, FA-3, FA-4, or FA-5) 
52 100 
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Table 2.1 Melting temperature of membrane proteins determined using the CPM-thermal 
denaturation method (continued). 
5-hydroxytryptamine 
Receptor (5-HT3R) 
50 mM Tris/HCl, 125 mM NaCl, 
0.010% (w/v) C12E9, pH 7.4 
61 101 
Human adenosine A2A 
receptor 
0.1% (w/v) DDM, 0.1% (w/v) 
CHAPS, and 0.02% (w/v) 
cholesteryl hemisuccinate (CHS) 
in 50 mM sodium phosphate 
buffer (pH 7.0) 
42 97 
Nociceptin/orphanin FQ 
peptide receptor (ORL1) 
50 mM HEPES (pH 7.5), 500 
mM NaCl, 20 mM KCl, 10% 
glycerol (v/v), 5 μM C-24, and 5 
× CMC of each detergent being 
tested. 
41.4-
61.4 
102 
Chemo-attractant receptor 
homologous 
10 mM HEPES (pH 7.0), 5 mM 
NaCl, 0.0053% (w/v) Fos16 
47-55 103 
nociceptin/orphanin FQ 
peptide receptor ORL-1 
50 mM HEPES (pH 7.5), 500 
mM NaCl, 20 mM KCl, 10% 
glycerol (v/v), 5 µM C-24, 1 mM 
DDM supplemented with various 
sterols 
56.6 104 
Opsin 10 mM HEPES (pH 7.5), 100 
mM NaCl, 0.1 mM MgCl2, and 
0.03% (w/v) DDM 
60.4/56.3 105 
 
Using the CPM thermal denaturation method, many research groups profiled membrane 
proteins and got their melting temperatures (Values of Tm from literature are shown in Table 
2.1). However, it is an interesting phenomenon that most of the values cluster into a narrow 
range of temperature around 45 oC to 55 oC. A thorough understanding of the mechanism 
behind the observed signal changes is critical for the interpretation of the protein-unfolding 
data. Here we investigated the thermal-denaturation process of two α-helical membrane 
proteins, AcrB and AqpZ, under different experimental conditions using the CD and CPM 
assay (Figure 2.1). AqpZ and AcrB are inner-membrane proteins from E.coli. The 
structures of both proteins have been determined. AqpZ is a tetrameric water-specific 
aquaporin. It contains two free Cys residues, at positions 9 and 20.106 AcrB is a trimeric 
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transporter and a component of the AcrAB-TolC multidrug efflux pump. It also contains 
two free Cys residues, C493 and C887, both in the transmembrane domain.107 Our 
experimental results revealed that the transition temperature determined using the CPM 
assay was irrespective of the exact location of the Cys residues, which is inconsistent with 
what would be expected from the currently accepted mechanism. To further investigate the 
mechanism of the observed signal change, we investigated the thermal denaturation of two 
soluble proteins, ovalbumin and lysozyme (Figure 2.1).Ovalbumin was chosen because it 
contains four free Cys.108 In contrast, lysozyme is a well characterized small soluble protein 
without free Cys.109 The comparison of unfolding profiles monitored using the CD and 
CPM methods, and the comparison of unfolding profiles of wild-type and mutant proteins, 
provided valuable insight into not only the proteins under study, but also the mechanism of 
the CPM assay. 
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Figure 2.1 Structure of proteins used in this study.  Free Cys residues are shown as spheres 
and their positions labeled.  In AqpZ, T107 and A27 are also shown and labeled.  
Ovalbumin and lysozyme contain one and four pairs of disulfide bonds, respectively.  
These disulfide bonds are highlighted using spheres and their positions marked with arrows.  
For AqpZ and AcrB, the side view of an individual subunit was also shown to highlight the 
locations of Cys.  
2.2 Materials and Methods 
2.2.1 AcrB and Aquaporin Z (AqpZ) expression and purification 
All reagents including ovalbumin and chicken egg white lysozyme were obtained from 
SIGMA (ST. LOUIS, MO) unless otherwise noted. All point mutations were introduced 
using the QuikChange Site-Directed Mutagenesis Kit following the instruction (AGILENT 
TECHNOLOGIES, SANTA CLARA, CA) and confirmed through DNA sequencing.  All 
plasmids containing genes coding AcrB and its variants were transformed into a 
BW25113ΔacrB gene knockout strain for expression to avoid contamination from 
chromosomal AcrB in cells. A single colony from the transformed plate was picked and 
inoculated into 5 mL medium containing the appropriate antibiotics. After 8 hours of 
incubation, the medium was used to inoculate 400 mL LB medium and cultured at 37 oC 
with shaking overnight. Target protein was purified immediately from the pellet when cells 
were harvested by centrifuge the next morning. The cell pellet was resuspended in the 
lysate buffer (20 mM phosphate buffer, 300 mM sodium chloride, pH 7.9) and then 0.5 
mM phenyl-methane-sulfonyl-fluoride (PMSF) was added into the buffer to inhibit the 
serine protease in the cell lysate. Then the buffer containing cell pellet was sonicated for 
20 minutes in ice/water bath with 5 s on/off intervals. The cell lysate was centrifuged at the 
31 
 
speed of 10000 rpm or 15317 ×g under 4 oC for 20 minutes. 2% Triton X-100 was used to 
extract the protein AcrB from the membrane when the pellet was resuspended. After 2-hour 
shaking in ice bath, the solution was centrifuged at 10000 rpm for 20 minutes and the 
supernatant was transferred into a column containing Ni-NTA and 10 mM imidazole. The 
mixture was incubated with shaking in the 4 oC freezer for 40 min to allow protein to bind 
with the Ni-NTA resin. Next, the column was drained, and washed with the lysis buffer 
supplemented with 50 mM of imidazole, before AcrB was eluted using the lysis buffer 
containing 0.5 M imidazole. The elution fractions were analyzed using SDS-PAGE to 
evaluate the purity and concentration of the samples. Fractions containing AcrB were 
collected and dialyzed overnight at 4 oC against a dialysis buffer (20 mM phosphate, 0.3 
M NaCl, 0.03% DDM (w/v), pH 7.9).  
 
Gene encoding aqpZ was amplified from the genomic DNA of E.coli K-12 using PCR and 
inserted into plasmid pET28a between two restriction enzymatic sites (NdeI and XhoI).  A 
vector-derived six-histidine tag was introduced at the N terminal of protein for the 
convenience of protein purification.  Primers used in the construction of expression 
plasmids were as follows: 5’-CATATGTTCAGAAAATTAGCAGCTGAATGTTTTGG 
and 5’-CTCGAGTTAAT CACGCTTTTCCAGCAGGGTC with restriction enzymatic 
sites underlined.  Cells were cultured at 37 °C in LB media containing 50 g/mL kanamycin 
to an OD600nm of approximately 0.6.  The protein expression was induced by the addition 
of IPTG to a final concentration of 1 mM.  After 5 hours, cells were harvested by 
centrifugation at 7,000×g for 10 min at 4 °C.  Cell pellets were stored at -80 °C before 
purification.  AqpZ was purified following the protocol described above for AcrB with 
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minor modifications.  In the elution step, the elution buffer contained 0.25 M imidazole, 
0.03% (w/v) DDM, 20 mM Na-phosphate, 0.3 M NaCl, pH 7.9.  Protein samples were 
dialyzed overnight over the same buffer in the absence of imidazole at 4°C.  The same 
buffer was used throughout this study as the assay buffer unless otherwise noted. Purity of 
proteins were examined using SDS-PAGE after Coomassie Blue staining.  Protein 
concentration was determined using Pierce BCA Protein Assay Kit (THERMAL 
SCIENTIFIC INC., ODESSA, TX).110 
 
2.2.2 Thermal denaturation analyses of model proteins 
Thermal denaturation was measured by monitoring the ellipticity at 222 nm with the 
increase of temperature at 2.0 deg/min and recorded every 4oC with 8 s equilibration time 
on a JASCO-J810 machine.  For ovalbumin and lysozyme, the ellipticity readings at each 
temperature were converted into a folded percent by designating the readings at 4 and 98oC 
as zero and 100% folded, respectively.  For AcrB and AqpZ, the ellipticity was normalized 
against the reading at 4oC to better represent the effect of mutations.  Each experiment was 
performed at least three times and values of Tm were analyzed using the Boltzmann 
equation as described.111; 96 
 
2.2.3 CPM fluorescence assay  
N-[4-(7-diethylamino-4-methyl-3-coumarinyl) phenyl] maleimide (CPM) was purchased 
from Invitrogen (GRAND ISLAND, NY).  The CPM reactivity experiment was conducted 
as described in literature with minor modifications.96 Briefly, a DMSO solution of CPM 
was freshly made at a concentration of 4.0 mg/mL.  It was diluted in the assay buffer by 
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40-fold to make a work solution of 100 μg/mL, which was kept on ice during the 
experiment.  30 μL of the CPM working solution was mixed with 570 μL assay buffer in 
which the final concentration of protein was 4 μM.  The fluorescence signal excited at 387 
nm and emitted at 463 nm was monitored upon heating.  Fluorescence emission intensity 
was normalized against the maximum intensity.  Each experiment was performed at least 
three times and values of Tm were analyzed using the Boltzmann equation as described.111; 
96 For studies with soluble proteins, DDM was left out from the assay buffer.  To evaluate 
the effect of covalent interaction, 30 μL of the CPM working solution was mixed with 570 
μL assay buffer containing 50 mM glycine (buffered at pH 8.0) and incubated at 80 oC in 
the dark for 30 min.  The samples were then cooled to 20oC before lysozyme was added to 
a final concentration of 4 μM.  The fluorescence intensity change upon heating was then 
monitored as described. 
 
2.3 Results and discussion 
2.3.1 Effect of pH on CPM fluorescence assay 
To investigate the effect of pH on CPM fluorescence assay, the change of fluorescent 
intensity of samples containing CPM alone or CPM with ovalbumin were monitored at 
different pH (Figure 2.2). The result illustrated that CPM itself had a small fluorescence 
surge (Figure 2.2, C), which is much smaller than the intensity measured in the presence 
of ovalbumin. This surge is due to the hydrolysis of the maleimide group and is sensitive 
to the change of pH (Figure 2.2, B). For the five trials, from higher pH to lower pH, Tm 
shifted from 22 oC, 36 oC, 63 oC, 70 oC, to 79 oC.  The rate of hydrolysis depends on the 
pH of the solution, and at higher pH the hydrolysis showed a lower Tm. However, Tm of 
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samples containing both CPM and ovalbumin in different pH buffer were very close. These 
results indicated that the reactivity of CPM with sulfhydryl group in ovalbumin was not 
affected drastically by pH. In the following studies, a sodium phosphate buffer at pH 7.0 
was used. 
 
Figure 2.2 The effect of pH on CPM fluorescence assay. A. CPM in the presence of 
ovalbumin (Normalized). B. CPM alone (Normalized). C. CPM alone and CPM with 
ovalbumin in pH 7 buffer (original intensity).  
 
2.3.2 Dilution of CPM dye with or without DDM 
A stock solution of CPM (4 mg/mL) was routinely prepared in DMSO. It was first diluted 
into an aqueous solution to make a work solution, which was diluted further into samples 
for the assay. We found that it was important to have detergent of low concentration in the 
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work solution during the first dilution step, while it was not necessary to contain detergent 
in the final assay buffer. As shown in Figure 2.3, if there was no detergent included in the 
work solution but there was in the final assay buffer, the data were still wired with poor 
reproducibility.  
 
Figure 2.3 CPM assay of ovalbumin. CPM dye was diluted in pH 7 PB buffer in the work 
solution without any detergent. The three colored lines indicate three trials using the same 
diluted CPM dye. A. CPM assay was conducted in PB buffer, original fluorescence 
intensity. B. Normalized intensity data of Panel A. C. CPM assay in PB buffer with 0.03% 
(w/v) DDM. D. Normalized data of Panel C.  
 
When detergent was included in the work solution but not in the final assay buffer, the 
36 
 
experimental result could be very reproducible (Figure 2.4). Tm of ovalbumin in phosphate 
buffer without DDM was 70.2 oC ± 0.9 oC while it was 64.6 oC ± 0.5 oC in phosphate 
buffer with 0.03% (w/v) DDM. We speculate that a small amount of detergent is necessary 
in the work solution to keep CPM soluble in water, so that it made the assays reproducible.  
 
Figure 2.4 CPM assay of ovalbumin with DDM dissolved dye. CPM dye was diluted in PB 
buffer with 0.03% (w/v) DDM in the work solution. The three colored curves represent 
three repeat trials. A. CPM assay was conducted in pH 7 PB buffer without DDM, original 
fluorescence intensity is shown. B. Normalized data of Panel A. C. CPM assay was in pH 
7 PB buffer with 0.03% (w/v) DDM. D. Normalized results of C.   
 
2.3.3 Effect of other detergents on CPM dilution 
To investigate whether other similar detergents had such an effect, SDS and Triton X-100 
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were tested. As DDM, the same concentration 0.03% (w/v) of the two detergents was used 
to dilute CPM dye and then CPM fluorescence assay of ovalbumin was conducted (Figure 
2.5). Tm was measured to be 66.9 oC ± 0.5 oC when SDS was used in the work solution, 
while it was 66.0 oC ± 1.3 oC when Triton X-100 was used in the work solution. No 
detergent was included in the assay buffer. The final detergent concentration in the sample 
was 0.0015% (w/v). The requirement of detergents in the work solution was not specific, 
as all tested detergents worked equally well. Critical micelle concentration (CMC) is an 
important characterization index for a detergent. CMC of DDM, SDS and triton X-100 are 
0.17 mM (0.009% w/v) 8.2 mM (0.2304%) and 0.24 mM (0.0155% w/v), respectively.112; 
113 Therefore, it is not necessary to use a detergent at a concentration higher than its CMC 
in the work solution. The lack of specificity further confirmed our speculation that a small 
number of detergent molecules are necessary to keep CPM fully soluble in the work 
solution.   
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Figure 2.5 CPM assay of ovalbumin in a phosphate buffer. The three colored lines indicate 
three repeat trials. A. CPM dye was diluted in phosphate buffer with 0.03% (w/v) SDS in 
the work solution. B. Normalized results of A. C. CPM dye was diluted in phosphate buffer 
with 0.03% (w/v) Triton X-100 in the work solution. D. Normalized results of C.  
 
2.3.4 CPM assay of AqpZ and its mutants 
We have constructed two AqpZ mutants, AqpZA27P and AqpZT107P.  The original goal was 
to improve the stability of AqpZ, since the introduction of a Pro residue into the β-turns 
had been reported to have a stabilizing effect on proteins.114 Both mutants could be 
expressed and purified at levels comparable to the wild-type protein.  Wild-type AqpZ 
migrated as a tetramer in SDS-PAGE, as reported in literature.115 Under the SDS-PAGE 
experimental condition, SDS did not abolish the non-covalent interaction between 
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neighboring subunits in the AqpZ tetramer.  While AqpZT107P also migrated as a tetramer, 
AqpZA27P migrated as a monomer.  This result suggested that the Ala27 to Pro mutation 
weakened the quaternary structure association.  The thermal denaturation profiles of all 
three proteins were first measured using CD (Figure 2.6, A and B).  AqpZ is a highly α-
helical membrane protein.  In the absence of urea, the helical content only decreased by a 
small portion upon heating.  AqpZT107P behaved similarly as the wild-type protein, while 
AqpZA27P had a lower Tm and reached a higher level of unfolding at 98oC.  To further 
investigate the relative stability of the three proteins, we repeated the experiment in the 
presence of 6 M urea.  In the presence of 6 M urea, the Tm of wild-type AqpZ dropped by 
~10oC.  The three proteins had similar Tm and unfolded to similar levels.  The difference 
between AqpZA27P and the other two proteins disappeared.  In summary, these results 
suggest that the Ala27 to Pro mutation decreased the oligomer stability, which subsequently 
caused the secondary structure to unfold at a lower temperature.  In the presence of 6 M 
urea, while the melting temperature of all three proteins decreased, the difference between 
A27P and the other two proteins disappeared.  We speculate the high concentration of urea 
must have disrupted the tetramer association, and thus eliminated the difference between 
the proteins. 
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Table 2.2 Tm of AqpZ and its mutants determined using the CD and CPM fluorescence 
assays in presence and in absence of 6M urea. 
AqpZ construct  
In absence of 6M urea In presence of 6M urea 
CD (oC) CPM assay (oC) CD (oC) 
CPM assay 
(oC) 
WT >100 52.2 ± 0.3 >90 42.1 ± 0.6 
A27P >90 53.5 ± 0.1 >90 43.6 ± 0.6 
T107P >100 53.1 ± 0.2 >90 44.0 ± 0.6 
 
 
Next, we repeated the thermal denaturation experiment and monitored protein unfolding 
using CPM fluorescence assay (Figure 2.6, C and D).  The transition temperatures were 
much lower than those observed using CD (Table 2.2).  While the lack of a plateau at the 
high temperature prevented the estimation of a melting temperate when monitored using 
CD, a clear transition followed by a plateau could be observed using the CPM fluorescence 
method.  In addition, all three proteins behaved similarly both in the presence and absence 
of urea, indicating that the CPM method was not sensitive to the change of quaternary 
structure resulted from the A27P mutation.  The presence of 6 M urea also decreased the 
Tm by approximately 10 oC.  
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Figure 2.6 Unfolding study of AqpZ and its mutants. A. In the absence of urea, monitored 
using CD. B. In the presence of 6 M urea, monitored using CD. C. In the absence of urea, 
monitored using the CPM fluorescence assay. D. In the presence of 6 M urea, monitored 
using the CPM fluorescence assay.  
 
2.3.5 CPM assay of WT-AcrB and its mutants 
We have shown in previous studies that when monitored using CD, the thermal 
denaturation profile of AcrB does not display a clear transition point and a high helical 
content remains at 98 oC.110 Using the CPM assay, a clear transition point could be observed 
(Figure 2.7).  To probe if the CPM assay is sensitive to the location of the reactive Cys, we 
created three mutants with a unique Cys at a carefully chosen position.  We first replaced 
the two intrinsic Cys residues C493 and C887 from AcrB to create CL-AcrB. On the CL -
AcrB background, we constructed two single Cys mutants, CL-AcrBS450C and CL-
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AcrBV105C.  In addition, we constructed a third mutant by replacing C493 with Ala, so 
AcrBC493A also only contains one free Cys residue (C887).  Locations of residues 
mentioned were shown in Figure 2.7. These sites represent Cys residues exposed at the 
trimer interface, in the soluble periplasmic domain (V105C) or transmembrane domain 
(S450C and C887).  The other intrinsic Cys, C493, is hidden in the core of the 
transmembrane helix bungle.  We expected the CPM thermal denaturation curve of 
different AcrB constructs to be different, depending on the exact location of the unique Cys 
residues.  CD spectra of all mutants superimposed well onto the spectrum of WT-AcrB, 
indicating that the mutations did not lead to a drastic conformational change (data not 
shown).  The CPM thermal denaturation plots of CL- AcrBV105C, CL- AcrBS450C, and 
AcrBC493A were similar to that of the wild-type AcrB, with Tm values within the error range 
to each other (Table 2.3 and Figure 2.7).  Considering the difference in locations of the Cys 
residues, the CPM assay seemed to be insensitive to the location of the reactive Cys. Since 
it is generally considered that during thermal denaturation, previously hidden Cys becomes 
more exposed upon protein unfolding and accessible for CPM labeling, the insensitivity of 
Tm to the location of Cys seemed to be very odd.  
Table 2.3 Tm of AcrB and its mutants determined using the CD and CPM fluorescence 
assays. 
AcrB Tm (oC) 
WT 52.8 ± 0.2 
CL-V105C 54.3 ± 0.7 
CL-S450C 54.5 ± 0.5 
C493A (C887) 54.9 + 0.6 
CL 56.6 ± 1.1 
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To further investigate the specificity of CPM labeling, we tested the thermal denaturation 
of CL-AcrB (Figure 2.7). Since there is no Cys in this protein, we used it as a control to 
investigate the necessity of Cys in the process.  We found the peak intensity of CPM 
fluorescence was lower in CL-AcrB.  In addition, the shoulder at a lower transition 
temperature, which was present in all AcrB constructs containing one or two Cys residues, 
was missing in the curve of CL-AcrB.  We speculate that this lower temperature transition 
might correspond to the reaction of Cys with CPM, which is immediately followed by a 
second transition.  Other than Cys, another possible residue for CPM labeling is Lys.  
Though at a lower rate, maleimide also reacts with the amino group.  Among the 1049 
residues in each AcrB subunit, there are 43 Lys.  And since Lys is in general exposed on 
the surface of a protein, it is not surprising that it may also react with CPM during the 
thermal denaturation process.  However, the reaction of surface exposed Lys with CPM 
should not require protein unfolding.  Then what does the transition temperature in the 
melting curve actually reveal?  
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Figure 2.7 Thermal denaturation of AcrB and its mutants. A. CPM fluorescence assay of 
WT-AcrB, AcrBV105C, AcrBS450C and AcrBC887 (actually AcrBC493A). B. Normalized data for 
CPM assay of WT-AcrB and CL-AcrB. C. CPM assay of WT-AcrB and CL-AcrB. 
 
Table 2.4 MICs of BW25113ΔacrB containing plasmid encoding the indicated AcrB 
constructs. 
 
Strain 
MIC(μg/mL) 
Erythromycin Novobiocin 
WT-AcrB 160 160 
AcrBV105C 40 40 
AcrBS450C 160 80 
AcrBC887 160 80 
AcrBD795C 160 80 
ΔacrB 20 40 
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2.3.6 CPM assay of urea denatured ovalbumin 
To understand the nature of the fluorescence surge in the CPM assay, we continued our 
study using two soluble proteins, ovalbumin and lysozyme.  With the increase of 
temperature, the detergent in the membrane protein studies may lead to artifacts and 
interfere with the experimental result.  By using soluble proteins, we could exclude 
detergent from the assay buffer and thus eliminate a potential source of artifact.  Thermal 
denaturation of ovalbumin was monitored using both CD and CPM.  As shown in the CD 
wavelength scan in Figure 2.8, ovalbumin retained certain secondary structure component 
even at the maximum temperature tested (98 oC). The structure transition occurred at a Tm 
of 66.3 ± 1.9 oC.  When temperature rose to 80 oC, protein structure no longer changed. 
The thermal denaturation curve of ovalbumin approached a plateau at approximately 80 oC 
as well when monitored using the CPM method, with a Tm of 65.0 ± 0.2 oC.  Therefore, the 
melting temperature of ovalbumin measured using these two methods were in good 
agreement.  This result validated the CPM assay as an approach to reveal protein stability.   
         
Table 2.5 Tm of soluble proteins determined using the CD and CPM fluorescence assay. 
 
Urea (M) CD (oC) CPM assay (oC) 
Ovalbumin   
0 66.3 ± 1.9 65.0 ± 0.2 
2 61.5 ± 1.3 49.2 ± 0.4 
4 57.1 ± 1.3 42.2 ± 0.5 
6 51.9 ± 0.4 37.4 ± 0.5 
Lysozyme   
0 74.2 ± 0.4 72.4 ± 0.2 
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To gain more insight into the nature of the CPM detection method, we repeated the thermal 
denaturation measurement in the presence of urea.  Thermal denaturation was performed 
in the presence of 2, 4, or 6 M of urea, and monitored using CD and CPM fluorescence.  
The Tm under each condition was determined and listed in Table 2.5.  The presence of a 
high concentration of urea prevented the collection of the CD spectra to wavelengths lower 
than 210 nm.  However, it was clear that less secondary structure presented in the protein 
at 98 oC when urea was present (Figure 2.8).  In addition, while the Tm determined from 
CPM fluorescence and CD methods were consistent in the absence of urea, the melting 
temperatures determined in the presence of urea were quite different.  The presence of urea 
led to a much larger decrease of the melting temperature when monitored using CPM 
fluorescence.  This result suggests that the presence of urea has a larger effect on the 
disruption of the hydrophobic core of ovalbumin than on the unfolding of the secondary 
structure. Even though high concentration urea and high temperature were used in 
denaturation of ovalbumin, the secondary structure did not completely unfold. Comparing 
to the secondary structure which was mostly α-helix at 4 oC, the secondary structure at 98 
oC was mostly β-sheet.  
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Figure 2.8 Study of ovalbumin unfolding with CPM assay and CD. A. Ovalbumin 
denaturation monitored using CPM assay in the presence of 0 M, 2 M, 4 M or 6 M urea. B. 
Urea denaturation of ovalbumin was monitored using CD. The concentration of urea 
solution was 0 M, 2 M, 4 M and 6 M.  
 
In summary, ovalbumin thermal denaturation monitored using CPM assay and CD were 
comparable in absence of urea. Tm obtained from these two methods were almost the same 
and the end points where the state transition finished were similar. In CD melting 
experiment, the secondary structure shifted from α-helix to β-sheet after high temperature 
denaturation while the overall unfolding of ovalbumin finished at about 80 ℃. The plateau 
of CD melting curve matched the end point of CPM assay, indicating that the structure 
transition completed at the same temperature 80 oC. However, in presence of urea, 
ovalbumin denaturation temperature monitored using CPM assay and CD displayed 
different results. The plateau of CD did not match the end point in CPM assay, indicating 
the structure transition did not finished at the same temperature. CPM assay monitors the 
opening up of the tertiary structure, while CD monitors the change of secondary structure. 
The effect of urea on protein structure seemed to be different at these two levels in 
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ovalbumin.  
 
Figure 2.9 Wavelength scan of ovalbumin in the absence or presence of urea at different 
concentrations at 4 oC (green) and 98 oC (blue). A. In PB buffer, no urea. B. In 2 M urea. C. 
In 4 M urea. D. In 6 M urea.  
 
2.3.7 CPM assay of lysozyme 
To investigate the specificity of the CPM reaction, we chose another well-characterized 
soluble protein to measure its melting temperature.  Chicken egg white lysozyme is a small 
soluble protein of 129 residues with four pairs of disulfide bond but no free Cys.  It contains 
6 Lys residues, all exposed to the surface of this small globular protein.  Thermal 
denaturation of lysozyme was monitored using both the CD and CPM fluorescence method.  
The melting temperatures were very similar (Table 2.5).   
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To exam if the reaction and formation of a covalent bond is important for the measurement, 
we first blocked the maleimide group in CPM using a pretreatment in the presence of a 
high concentration (50 mM) of glycine, and then monitored the fluorescence intensity of 
the treated CPM in the presence of lysozyme upon heating (Figure 2.10).  The initial 
fluorescence intensity was much higher than CPM without pre-treatment, due to the 
chemical reaction between maleimide and glycine.  As monitored earlier, reaction of the 
maleimide group led to an increase of fluorescent signal. With the increase of temperature, 
the fluorescent intensity first gradually decreased due to a non-specific collision quenching 
effect.  At the transition point of lysozyme unfolding, a sharp increase of the fluorescence 
could still be observed, indicating that the observed fluorescence increase did not require 
covalent attachment of the fluorophore to the protein.  In the control samples lacking 
lysozyme, or in the presence of just DTT, a peak could not be observed.  These results 
confirmed that the peak observed was actually due to interaction between CPM and 
lysozyme. 
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Figure 2.10 Thermal denaturation of lysozyme. A. Denaturation monitored using CD at 222 
nm. Ellipticity at different temperatures was converted into a folded percentage as 
described in Materials and Methods.  B. Normalized fluorescence intensity during 
denaturation as monitored using the CPM assay.  C. Interaction of pre-treated CPM with 
lysozyme (blue squares).  Pre-treated CPM in the assay buffer (yellow diamonds) and in 
the presence of 1 mM DTT (green triangles) were shown as controls.  The curve of 
lysozyme reacted with CPM not subjected to pre-treatment was also shown again as a 
control (red triangles).   
 
2.3.8 CPM kinetics study of AcrB quaternary structure 
To investigate the usefulness of the CPM fluorescence method in detecting protein 
quaternary structure stability, we monitored the increase of CPM fluorescence over time at 
a constant temperature (30 oC).  We used five AcrB constructs in this study, the wild-type 
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(WT) protein and four mutants, W13C, W895C, W13C/P223G, and W895C/P223G.  All 
four mutants were created on the CL-AcrB background. W13 and W895 belong to 
transmembrane helices 1 and 8, respectively.  Both are on the inter-subunit interface in the 
transmembrane domain.  We have shown that W13C and W895C mutations do not affect 
AcrB function, indicating that the mutants still exist as trimers.116 The P223G mutation has 
been shown previously to disrupt AcrB trimer stability.114 Therefore, CL-AcrBW13C and 
CL-AcrBW895C are trimers, while the corresponding P223G mutants are monomers.  The 
increase of the CPM fluorescence signal in the presence or absence of proteins was 
monitored at 30 oC for 2 min with excitation and emission wavelengths of 387 and 463 nm, 
respectively (Figure 2.11, A).  The slopes of the traces were determined, which reflected 
the rate of CPM reaction with the protein (Figure 2.11, B).  The reaction rates between 
CPM and CL-AcrBW13C or CL-AcrBW895C were similar to the rate of CPM reaction with 
wild-type AcrB, which was significantly slower than the reaction rate with the 
corresponding P223G mutants (Figure 2.11, B).  This observation is consistent with the 
expectation from their quaternary structure, indicating that the CPM fluorescence method 
in the kinetic mode could reveal information about protein quaternary structure stability.   
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Figure 2.11 Kinetics of CPM-AcrB interaction. A. Representative traces of CPM 
fluorescence intensity increase over time in the absence (black diamonds) or presence of 
wild-type AcrB (black triangles), CL-AcrBW13C (black squares), CL-AcrBW13C/P223G (open 
triangles), CL-AcrBW895C (open diamonds), CL-AcrBW895C/P223G (open squares). B. Rate as 
obtained from the slope of the traces.  Each experiment was conducted at least three times. 
The average values and standard deviations are shown.  
 
2.4 Discussion and conclusion 
In this study, we investigated the thermal denaturation of four proteins using the CD and 
CPM fluorescence methods.  This study was prompted by the observation that the Tm of 
membrane proteins determined using the CPM fluorescence method reported in literature 
are closely clustered, with most of them in the temperature range of 45-55 oC (Table 2.1).  
The melting temperatures of AqpZ and AcrB were found to be in the range as well.  If this 
narrow range of stability is not a measurement artifact, then it may reflect the fact that the 
cell membrane is a somewhat limited environment, which eliminated the requirement of a 
large variation of protein thermal stability.  Another possibility is, the intrinsic differences 
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between membrane proteins were not faithfully reflected when probed in detergent 
micelles.  It has been established that the Tm is sensitive to the presence of different lipid 
molecules. Another interesting observation is the different effect of urea on Tm measured 
using CD or the CPM method.  For example, in the absence of urea, Tm of ovalbumin was 
similar when measured with the two methods. However, in the presence of 2 M urea, the 
Tm dropped by 5oC and 15oC, respectively, when measured using the CD or the CPM assay. 
The first step of protein unfolding was the expansion of the hydrophobic core, in both 
thermal denaturation and urea denaturation.117 The presence of urea during thermal 
denaturation clearly lowered the energy barrier for the disruption of the hydrophobic core, 
allowing easier access for the fluorescence probe. 
 
Based on our study, we found that the Tm measured using the CPM assay does correlate 
with protein unfolding, although the exact mechanism of fluorescence surge was not as 
previously proposed.  In a sense, this makes the method even more useful, since the 
presence of free Cys residues is no longer a prerequisite.  The chemical reaction and 
subsequent covalent attachment is not critical for the observed increase of fluorescence 
signal.  This mechanism can also explain the observed lack of sensitivity to neither the 
exact location of reactive Cys nor protein quaternary structure. The CPM fluorescence 
surge reflects the expansion of the hydrophobic core and oligomer dissociation is not likely 
to generate such an effect. Different locations of cysteine showed different CPM reaction 
rate, indicating that CPM thermal stability assay could be used to evaluate protein 
quaternary structure.  
 
As discussed above, CPM could be coupled with thermal denaturation to monitor protein 
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unfolding. Here we also investigated the usage of CPM to study protein quaternary 
structure through monitoring the kinetics of labeling. According to the location of a 
cysteine in a protein, the accessibility for CPM is different. Therefore, we expect to observe 
different reaction rate. Based on this analysis, measurement of fluorescence increase over 
time will provide insight into the accessibility of a specific Cys residue. When coupled 
with careful design for the location of the reporter Cys residue, information can be obtained 
regarding protein quaternary structure.   
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Chapter Ⅲ. Repressive Mutations Restore Function-loss Caused by the Disruption 
of Trimerization in Escherichia. Coli Multidrug Transporter AcrB 
 
Part of this chapter are taken from “REPRESSIVE MUTATIONS RESTORE FUNCTION-
LOSS CAUSED BY THE DISRUPTION OF TRIMERIZATION IN ESCHERICHIA 
COLI MULTIDRUG TRANSPORTER ACRB”, 2015, Frontiers in Microbiology. 6, 4.122  
 
 
3.1 Introduction 
Escherichia coli transporter protein AcrB as well as its homologues are the inner membrane 
components of the RND family efflux pumps.118 AcrB, together with membrane fusion 
protein AcrA and outer membrane protein TolC, forms a tripartite pump system. The proper 
function of AcrB requires the accurate assembly of the tripartite complex. While extensive 
studies have been conducted to understand substrate binding, proton relay, and interaction 
between AcrB with AcrA/TolC, relatively less effort has been devoted to investigating the 
trimerization of AcrB and the relationship between trimerization and other functional 
aspects.  
 
To date, more than 30 crystal structures of AcrB, with or without substrates, have been 
deposited in the Protein Data Bank. AcrB is an obligate asymmetric homo-trimer.119 Each 
protomer consists of 12 transmembrane helices (TMH, transmembrane domain) and two 
large periplasmic loops (LPL, periplasmatic domain) with more than 300 amino acids 
(Figure 3.1, A).46 The first LPL (LPL1) locates between TMH1 and TMH2, while the 
second LPL (LPL2) locates between TMH7 and TMH8. In translocation of protons, 
important residues such as D407, D408, K940, and T978 could form salt bridge/hydrogen 
bonding networks among TM4, TM10, and TM11 (Figure 3.1, B).120 Mutations D407A, 
D408A, K940A, and T978A disable AcrB pump by distorting or disrupting the regular H-
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bonding interactions of the backbone H and C=O groups characteristic of α-helix.120  
The fact that a long-extended loop in one AcrB subunit also inserts into the neighboring 
subunit is clearly critical to the formation of AcrB trimer. Relatedly, through mutations and 
truncation of such loop, we have created a well-folded monomeric AcrB mutant. Our group 
has found that a single Pro223 to Gly mutation is sufficient to disrupt trimerization resulting 
in a drastic loss of function.110  
 
 
Figure 3.1 A. Topological model for AcrB efflux pump, showing two LPLs. Taken from 
the reference with minor modification.121 B. Model for putative salt bridge/hydrogen-
bonding network D407-D408-K940-T978 in AcrB protomer, modified from PDB file 
1IWG according to reference. The size and location of TM and residue are not shown in 
scale.120  
 
To advance our understanding about interactions that stabilize AcrB trimer, random 
mutagenesis was conducted to identify suppressor mutations that restore functions to 
AcrBP223G. Nine single mutations were found to restore the function of AcrBP223G (Table 
3.1). We originally expected the suppressor mutant to restore function by strengthening the 
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trimer association, as we hypothesized that the loss of activity in AcrBP223G was due to 
reduced trimer affinity.  However, purification and blue native-PAGE (BN-PAGE) analyses 
showed that none of the mutants significantly improved the content of AcrB trimer.  
 
Table 3.1 The results of drug susceptibility assay of AcrB mutants.122 
Plasmids 
MIC (µg/ml) 
Ery Nov Tet TPP R6G 
pQE70-AcrB (positive 
control) 
128 320 2.56 320-640 >640 
pQE70-AcrBP223G 8 40-80 0.64-1.28 20-40 40-80 
pQE70-AcrBP223G/T199M 128 160 2.56 320-640 >640 
pQE70-AcrBP223G/A209V 64 80 1.28 40-80 >640 
pQE70-AcrBP223G/D256N 32-64 160-320 2.56 320 >640 
pQE70-AcrBP223G/G257V 64 160 2.56 80-160 >640 
pQE70-AcrBP223G/M662I 64-128 80 1.28 160 160 
pQE70-AcrBP223G/Q737L 64 160 2.56 160-320 >640 
pQE70-AcrBP223G/D788K 128 160 2.56 160-320 160-320 
pQE70-AcrBP223G/P800S 64 80 1.28 40-80 >640 
pQE70-AcrBP223G/E810K 128 160 2.56 160-320 >640 
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Here we investigated the mechanism of function restoration of the suppressor mutants. The 
suppressor mutants could be clustered according to their location. Eight out of the nine 
mutants (Figure 3.2) which restored the activity of AcrBP223G locate in the docking domain. 
The last mutation M662I is in the porter domain, which is far from the outer membrane 
channel protein TolC, so we chose this mutation as our research objective.  
 
Figure 3.2 Structure of AcrB monomer. P223 is colored in yellow while suppressor mutants 
are colored in red.  
 
3.2 Materials and Methods 
3.2.1 Sited directed mutagenesis, expression and purification 
Sited directed mutagenesis, protein expression and purification were conducted as 
described in section 2.2.1.  
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3.2.2 Analyses of secondary structure using circular dichroism (CD) spectroscopy 
The secondary structure of AcrB variants were characterized with CD spectroscopy 
conducted on a JASCO J-810 spectrometer. The protein samples were dialyzed into a low 
salt buffer (10 mM sodium-phosphate, 50 mM NaCl, 10% glycerol, 0.03% DDM, pH 7.5) 
before the CD measurement. Blank scans were collected using the dialysis buffer. The 
spectrum wavelength scans were collected from 255nm to 195nm in a 1 mm path-length 
cuvette. CD thermal denaturation experiments were performed using the same 
spectrometer with a PELTIER temperature controller as described.123 Thermal denaturation 
was measured by monitoring the ellipticity at 222 nm with the increase of temperature at 
2.0 oC/min and recorded every 4 oC with 8 s equilibration time.  
 
3.2.3 Cross-linking of AcrA-AcrB in intact cells  
The plasmid pET22 containing wild type acrA (wt-acrA) was co-transformed into 
acrA/acrB knockout strain with the plasmid pBAD33 containing wt-acrB, or acrBP223G, or 
acrBP223G/M662I for expression. A single colony was picked from a freshly transformed plate 
and grown with shaking at 37°C in 3 ml LB medium containing 100 μg/ml of ampicillin 
and 50 μg/ml of kanamycin for 8 hours. 2 ml of this cell culture was used to inoculate 200 
ml LB medium containing 100 μg/ml of ampicillin and 50 μg/ml of kanamycin overnight. 
Cells were harvested by centrifugation at 5000×g for 10 min. The cell pellet was 
resuspended in 10 ml cross-linking buffer (20 mM sodium phosphate, 300 mM NaCl, pH 
7.2) and incubated with 0.4 mM dithiobis succinimidyl propionate (DSP) cross-linker at 
37°C for 30 min. After quenched with 20 mM Tris, cells were centrifuged, harvested and 
resuspended in lysis buffer (20 mM Tris-HCl, 300 mM NaCl, pH 8.0).  The proteins were 
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purified as described in the previous paragraph.  
 
3.2.4 Chemical denaturation  
Unfolding of AcrB by chemical denaturants was monitored as described with slight 
modification.124 Briefly, protein unfolding was initiated by titrating concentrated urea (8.0 
M) or SDS (0.2% or 2%, w/v) into 400 μL of freshly purified AcrB in the dialysis buffer 
(20 mM phosphate, 0.3 M NaCl, 0.03% (w/v) DDM, pH 7.5). A fluorescence emission 
spectrum between 300 to 400 nm was recorded at each titration point with a LS-55 
fluorescence spectrometer (PerkinElmer, Inc., Waltham, MA) with excitation wavelength 
of 280 nm. The intensity of the fluorescence peak was collected and converted into fraction 
of protein folded through normalizing to the reading before the addition of the denaturant, 
and plotted as a function of urea molar concentration or SDS/DDM molar ratio. A titration 
plot of L-tryptophan with SDS was used as a control to confirm the lack of a non-specific 
effect of SDS on fluorescence emission. 
 
3.2.5 CPM thermal stability assay 
The CPM reactivity experiment was conducted as described in literature with minor 
modifications.96 Briefly, a DMSO solution of CPM was freshly made at a concentration of 
4.0 mg/mL.  It was diluted in the assay buffer by 40-fold to make a work solution of 100 
μg/mL, which was kept on ice during the experiment.  30 μL of the CPM working solution 
was mixed with 570 μL assay buffer in which the final concentration of protein was 4 μM.  
The fluorescence signal excited at 387 nm and emitted at 463 nm was monitored upon 
heating.  Fluorescence emission intensity was normalized against the maximum intensity.  
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Each experiment was performed at least three times and values of Tm were analyzed using 
the Boltzmann equation as described.111; 96   
 
3.3 Results  
3.3.1 Analyses of secondary structure with CD 
To investigate whether the second mutation M662I had any influence on the secondary 
structure of AcrBP223G, CD was conducted according to the protocol as described in method. 
CD is a spectroscopic technique measuring the differential absorption of left and right-hand 
circular polarized light for certain chiral molecules. For proteins, CD provides a lot of 
information including secondary structure composition, tertiary structure fingerprint, 
integrity of cofactor binding sites, conformational changes, and protein folding and 
conclusion about the overall structure. Far-UV CD spectra (240 nm and below) is useful to 
analyze the secondary structure of proteins, because different spectra are associated with 
different secondary structure types: α-helix, β-sheet, β-turn, irregular structure, etc.125; 94 
CD analysis was conducted to evaluate the second structures of the three proteins WT-
AcrB, AcrBP223G and AcrBP223G/M662I at the same concentration of 0.37 μM (Figure 3.3). 
The original unit of millidegree “mdeg” was converted into mean residue ellipticity (MRE) 
according to the following equation: 
[θ] =
𝜃
10 × 𝑐 × 𝑙
 
where [θ] with a unit of “degree•cm2/dmol-1” indicates MRE, θ indicates mdeg obtained 
from the spectrometer, c is the molar concentration of the sample (mol/L), and l is the 
pathlength in cm.126 Two negative peaks around 208 nm and 222 nm and one positive peak 
at around 193 nm which are characteristic peaks for α-helices were present.127 The 
62 
 
secondary structures of the three proteins were almost identical according to the CD spectra 
obtained, which suggested that the second mutation M662I did not have an observable 
effect on the secondary structure.  
 
 
Figure 3.3 CD spectra of WT-AcrB, AcrBP223G and AcrBP223G/M662I. 
 
3.3.2 Chemical cross linking of AcrA-AcrB in intact cells 
Another factor which may result in the recovery of the efflux function of AcrBP223G is that 
the mutation M662I may increase the interaction between AcrB and its partner proteins 
AcrA or TolC. Here we used chemical cross-linking to determine whether M662I improved 
the interaction. Chemical cross-linking is a useful technique for probing the interaction 
between proteins in large protein complexes.128 Several types of cross-linkers have been 
applied to identify the cross-linked products, such as isotope-labelled cross-linkers or 
proteins, fluorogenic cross-linkers and cleavable cross-linkers.129 Among them, DSP, an 
amine-reactive cross-linker having NHS-ester reactive ends and a cleavable disulfide bond 
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in its spacer arm,130 was used as cross-linker to investigate the potential effect of M662I on 
the interaction between AcrA and AcrB in cells in the study. The experiment was conducted 
as described in Materials and Methods, and SDS-PAGE and Western blot were used to 
quantify the amount of AcrA crosslinked with AcrBP223G and AcrBP223G/M662I. WT-AcrB 
was used as the positive control (Figure 3.4). The levels of AcrA cross-linked, and thus 
pulled down by AcrB, were similar. This result did not support the hypothesis that the 
repressor mutation restore function via improving interaction with AcrA.   
 
Figure 3.4 Cross-linking experiment was used to determine the level of AcrA interacting 
with different AcrB constructs. AcrA does not bind to Ni-NTA beads. Only those cross-
linked with AcrB would be purified and detected in the anti-AcrA immunoblotting. The 
P223G mutation did not decrease the level of AcrA crosslinked with AcrB, and the 
additional repressor mutation M662I did not increase the level either.  
 
64 
 
3.3.3 Protein stability determination of WT-AcrB, AcrBP223G and AcrBP223G/M662I by 
thermal denaturation in a CD instrument.  
To determine whether M662I restored the function of AcrBP223G by increasing the protein 
stability, thermal denaturation was conducted and monitored using a CD instrument. CD 
signal at 222 nm primarily associated with α-helical structure has been extensively used to 
assess the thermal stability of membrane proteins in vitro.131 In the study, the change of the 
CD signal at 222 nm was used to evaluate the change of secondary structure when purified 
protein lost secondary structure during thermal denaturation. All the data obtained from 
CD were normalized and converted into folded fraction according to the following 
equation: Folded fraction =
𝑌
𝑌𝑚𝑎𝑥
, where Y indicated the value of MRE normalized and 
Ymax indicated the maximum value which was defined as 100% folded.  
 
The result showed around 80% α-helices was lost for all three proteins when the 
temperature increased to 98 oC (Figure 3.5, A).  The ellipticity at 222 nm did not recover 
when temperature lowed back to 4°C, indicating that the unfolding was irreversible (data 
not shown). The similar melting curves of WT-AcrB, AcrBP223G and AcrBP223G/M662I 
resembled their structure similarity and the additional mutation M662I did not have an 
observable influence on protein stability.  
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Figure 3.5 Protein stability was assessed by thermal denaturation on CD machine. A. 
Thermal denaturation curves of WT-AcrB, AcrBP223G, and AcrBP223G/M662I. B. Boltzmann 
fit of WT-AcrB. C. Boltzmann fit of AcrBP223G. D. Boltzmann fit of AcrBP223G/M662I. 
 
To compare the curves more accurately, all the data were analyzed through OriginLab 9.0. 
Boltzmann equation,132 shown in the following, was applied to fit all the data (Figure 3.5, 
B, C, and D). 
Folded fraction =
𝐴1 − 𝐴2
1 + 𝑒(𝑇−𝑇𝑚) 𝑑𝑇⁄
+ 𝐴2 
where A1 and A2 represent the minimum and maximum value of denaturation, T represents 
the temperature, and Tm represents the melting temperature.   
 The result showed that R square is greater than 0.99, indicating most of the data were 
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covered in the equation. Tm obtained from CD are similar without significant difference 
(Table 3.2), suggesting that all the three proteins had similar secondary structure and 
confirmed the result obtained from CD wavelength scan.  
 
Table 3.2 Protein melting temperature calculation results. 
Strain Melting temperature (Tm, oC) 
WT-AcrB 63.2 ± 0.5 
AcrBP223G 63.8 ± 0.6 
AcrBP223G/M662I 64.3 ± 0.6 
 
3.3.4 Chemical denaturation of WT-AcrB, AcrBP223G and AcrBP223G/M662I induced by 
SDS 
Chemical denaturation, a method of rendering proteins unfolding via addition of 
denaturants, is commonly used to characterize the conformational stability of globular 
proteins. Some spectroscopic methods such as fluorescence or CD are used to monitor the 
process in the denaturation assay. In this study, SDS denaturation was conducted through 
titrating aliquots of concentrated SDS solution into a solution of AcrB, and intrinsic 
fluorescence excited at 280 nm was recorded. The peak emission intensities at each SDS 
concentration were converted into folded percentage. As described in Figure 3.6, WT-AcrB 
showed the highest resistance to SDS while AcrBP223G/M662I had lowest resistance. 
Comparing to the curve of WT-AcrB, AcrBP223G/M662I did not recover the folding according 
to the denaturation curves.  
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Figure 3.6 SDS denaturation of WT-AcrB, AcrBP223G and AcrBP223G/M662I and Boltzmann 
fit of the three curves. 
 
3.3.5 CPM thermal denaturation analysis of WT-AcrB, AcrBP223G and AcrBP223G/M662I 
monitored on a fluorescence spectrometer.  
CPM thermal stability assay was widely used to evaluate the stability of protein.  A 
fluorescence dye CPM is supposed to interact with the hydrophobic core when the proteins 
unfold due to thermal denaturation. 132; 134 In CPM thermal stability assay, all the three 
proteins showed similar curves (Figure 3.7) and Tm (all the P values are greater than 0.05, 
which indicated that there was no significant difference), suggesting that the overall 
structure or the stability for all three AcrB variants are almost identical.134 The values 
obtained from data analysis (Table 3.3) also showed there was not significant difference, 
although the values obtained seemed different. Both results suggested that the second 
mutation M662I did not increase the stability of AcrB. 
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Figure 3.7 CPM thermal denaturation of WT-AcrB, AcrBP223G and AcrBP223G/M662I 
monitored using fluorescence spectrometer. A. CPM thermal denaturation curves of all the 
three proteins. B. Boltzmann fit of WT-AcrB. C. Boltzmann fit of AcrBP223G. D. Boltzmann 
fit of AcrBP223G/M662I.  
 
Table 3.3 Protein melting temperature (Tm) fitting results. 
Strain Tm (oC) 
WT-AcrB 52.9 ± 0.2 
AcrBP223G 51.7 ± 0.2 
AcrBP223G/M662I 54.0 ± 0.3 
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3.4 Discussion and conclusion 
Several factors are critical for the proper function for AcrB: drug binding, interaction with 
AcrA and TolC, proton relay through the transmembrane domain, and AcrB trimerization. 
In this study, firstly we identified nine single suppressor mutations that could restore 
function to AcrBP223G. Trimer affinity of purified mutants was examined using BN-PAGE. 
Although three mutants had higher trimer stability than AcrBP223G, while remained 
drastically lower than that of the WT-AcrB including the mutation M662I. Stability assay 
was conducted using three different methods, thermal denaturation monitored using CD, 
chemical denaturation and CPM thermal stability assay monitored by fluorescence 
spectrometer. All the results showed that M662I did not improve the stability of AcrBP223G. 
The next factor we tested was the interaction with partner proteins. We chose to investigate 
the interaction between AcrA and AcrB, since they make direct contact according to both 
wrapping model and bridging model. However, western blot results showed that M662I 
did not increase the interaction between them. At last, we determined whether M662I 
increased the substrate binding. Using a fluorescent labelling experiment, we found that 
M662 is involved in drug translocation pathway. Substrate binding in AcrB involves 
mainly hydrophobic interactions, and Ile is slightly hydrophobic than Met according to 
hydrophobicity scales generated by different studies.135 It is interesting to notice that such 
a small change of hydrophobicity could significantly increase the MIC for all substrates 
tested.122 We further measured the level of labeling of residue in the deep binding pocket, 
D276C (Figure 3.8). We found that the M662I mutation doubled the relative level of 
labeling at this site on the P223G background. Finally, we confirmed that the additional 
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M662I mutation did not induce an observable change on AcrBP223G structure and stability. 
While ligand-induced oligomerization has been observed in many receptor and signaling 
proteins, the ligand binding sites in these cases usually locate at the inter-subunit 
interface.136 In AcrB, the substrate translocation pathway, including M662, is distant from 
the inter-subunit interface. Therefore, the potential effect on AcrB trimer stability, if any, 
has to be allosteric. Interaction between neighboring subunits in an AcrB trimer is clearly 
critical for function. During drug efflux, each subunit adopts a different conformation and 
cycles through the three conformations in turn. Recently researchers determined the 
structure of AcrB at high enough resolution to resolve unambiguously the side chains of 
critical residues involved in proton translocation in the transmembrane domain and 
rationalized how the cross-talk among protomers across the trimerization interface might 
lead to a more kinetically efficient efflux system.137 Therefore, each subunit has to be able 
to “sense” the state of it’s the state of its neighbors and undergoes conformational change 
in a concerted manner. A key element differentiates the various conformational states is the 
mode of interaction with the substrate. Therefore, it is possible that improved interaction 
with substrate could enhance efflux activity either directly through more efficient uptake 
or indirectly via increasing trimer affinity. Interestingly, some ligands are found to enhance 
the transport of other ligands by AcrB, suggesting that ligand binding could potentially 
play a more active role in efflux.138   
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Figure 3.8 Bodipy-FL-maleimide labeling of residues on the substrate translocation 
pathway. Taken from the reference and done by Meng.122 A. Labeling of WT-AcrB, 
AcrBM662C, and AcrBF664C. The same gel was stained using Coomassie blue stain. The two 
bands in the molecular weight marker are 120 kDa (top) and 85 kDa (bottom). B. Labeling 
of AcrBD276C, AcrBP223G/D276C, and AcrBP223G/D276C/M662I. The same gel was stained using 
Coomassie blue stain. The level of labeling in AcrBP223G/D276C and AcrBP223G/D276C/M662I was 
normalized to the level of labeling in AcrBD276C. The average value and standard deviation 
of three independent experiments were shown. 
 
AcrB binds with substrates from the periplasm and extrudes them through the docking 
domain.119 In this process, there are two pockets in the periplasmic domain of AcrB that 
are involved in drug transport, the proximal binding pocket and distal binding pocket.52 
Considering that M662I did not change the stability of AcrBP223G, or increase the trimer 
association, or increase the interaction with its functional partner, we speculate that there 
may be two other reasons behind the activity restoration of AcrBP223G: 1) it perhaps 
increased the binding of AcrB binding pockets with substrates; 2) it may increase the 
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interaction between AcrB and TolC due to the allosteric effect caused by suppressor 
mutations. Study of the mechanism of functional restoration in suppressor mutation will 
greatly improve our understanding about the interplay between different aspect of AcrB 
function, which may eventually lead to new insight into how this delegate molecular 
machinery function to effectively efflux a large variety of compounds.  
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Chapter Ⅳ. Application of FRET in Study of AcrB Trimer Association 
 
4.1 Introduction 
Protein biosynthesis is an essential process to generate new proteins by cells. This process 
generally includes transcription, translation, protein folding, and post-translational 
modification.139-141 In each step, many factors work together to ensure the whole 
complicated process proceed accurately and efficiently. When protein biosynthesis starts, 
protein initiation factors including IF1, IF2, and IF3 activate the translocation of mRNA 
and formylmethionyl-tRNAf to ribosome. Elongation factor EF-Tu delivers aminoacyl-
tRNA to A site of ribosome while EF-G mediates translocation of mRNA and tRNA out of 
ribosome. Protein synthesis in ribosome is terminated by release factors (RFs) which could 
recognize stop codons UAA, UAG, and UGA.142 Post-translational modification is another 
important step during or after protein biosynthesis. To date, there are more than 300 post-
translational modification reactions identified,143 among which phosphorylation is the most 
pervasive and best-studied post-translational modification reaction given that it participates 
in many enzymes’ modulating activities.144   
 
Through translation in ribosome, a polypeptide chain is synthesized. After that, nascent 
polypeptide chains need to fold into three-dimensional conformations and sometimes 
oligomerize into oligomers in order to function normally. However, the folding and 
oligomerization of polypeptide chains are elusive, especially for membrane proteins. There 
are two main types of membrane proteins: α-helical membrane proteins and β-barrel 
membrane proteins. Folding of integral α-helical membrane proteins is considered to 
follow a two-stage pathway, which begins with the folding and membrane insertion of the 
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hydrophobic α-helices, followed by the interaction of those α-helices to form tertiary 
structure.145 This two-stage pathway is informed by the bacteriorhodopsin, an α-helical 
membrane protein with seven α-transmembrane helices.146 Folding of β-barrel membrane 
proteins happens partially before insertion.147  
 
Oligomerization is another important process for proteins to function properly. The 
oligomeric proteins, accounting for over 35% proteins in cells,  are essential in many 
cellular processes, including mediating gene expression, regulating enzyme activities, and 
ion channels, etc. 149 Although the mechanism of oligomerization is not well understood, 
results from several studies could shed light on following studies.148 In one study cadherin 
monomers was found to dimerize via “swapping” their N-terminal β-strands of the 
adhesive domains.149 In another study, Naveed et al found that β-barrel membrane protein 
can oligomerize through the weakly stable interfacial β-strands.150 Naveed et al also found 
that the structure and amino acid sequence of β-barrel membrane proteins can be used to 
assess the protein stability and predict whether these proteins are monomers or oligomers 
with an 91% accuracy rate.  
 
Many different techniques have been developed to determine and characterize protein 
oligomerization. In vitro, biophysical techniques such as size exclusion chromatography, 
NMR spectroscopy, scattering techniques, isothermal titration calorimeter, mass 
spectroscopy, and fluorescence anisotropy are commonly used. In cells, cross-linking, 
fluorescence method, proximity imaging, and complementation approaches are widely 
applied.151 Among the techniques developed to investigate protein oligomer association, 
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FRET is one of the few methods that are compatible with studies of membrane proteins in 
a lipid bilayer environment. One unique advantage of using fluorescent protein as fusion 
tags is that it eliminates the laborious labeling process after protein purification. In addition, 
the ratio of “labeling” is strictly controlled at a one-to-one ratio (i.e. one target protein with 
one fusion tag), which largely guarantees the sample to be homogenous. GFP and its 
derivatives are popular tools in studies of protein-protein interaction.152 GFP is firstly 
isolated from jellyfish Aequorea Victoria.153 In 1994, Martin Chalfie and his colleagues 
first expressed the cDNA in Escherichia. coli and Caenorhabditis elegans and found the 
main excitation peaked at 395 nm with a minor peak at 470 nm and emitted at 509 nm with 
a shoulder at 540 nm.154 GFP has been exploited in many studies because of its bright and 
stable fluorescence signal. To broaden the application spectra of GFP, derivatives such as 
CFP and YFP have been created by mutating certain residues in the protein sequence. When 
the tyrosine at position 66 is substituted by tryptophan, the excitation and emission 
wavelengths are changed into 436 nm and 476 nm, respectively. The mutations S65G, 
S72A and so on in the GFP gene sequence create YFP with a wavelength of emission at 
529 nm, when excited at 514 nm (Figure 4.1).153 CFP and YFP have been used as a FRET 
pair in many studies to probe protein-protein interaction or conformational changes.155 
Using FRET between fluorescent protein pairs CFP and YFP, Miyawaki et al 156 
investigated the interaction between two proteins (calmodulin and M13) in response to an 
increasing concentration of Ca2+. When the two fluorescent proteins are fused into the same 
host protein, intramolecular FRET can be used to study the conformational change of the 
protein. Kurokawa et al 157 used this method to investigate the conformational change of 
phosphorylated adaptor protein, CrkⅡ, in vivo and found epidermal growth factor-induced 
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phosphorylation of CrkⅡwas initiated at the peripheral plasma membrane.  
 
Figure 4.1 Fluorescence excitation and emission of CFP and YFP.158;159  
 
Although the crystal structure of AcrB was revealed in 2002 and the whole complex 
AcrAB-TolC was resolved in 2014, how native synthesized AcrB monomers assemble into 
AcrB trimers remains elusive. Lu et al. in 2011 probed into the question that whether 
individual subunits of AcrB fold into monomers before all subunits assemble into a trimer 
(three-stage pathway) or simultaneously (two-stage pathway).110 The existence of well-
folded monomeric AcrB mutant AcrBΔloop, in which the protruding loop was deleted, 
suggested that oligomerization occurred through a three-stage pathway. Later, Lu et al. 
found that AcrB trimerization in vivo is not completely random.160 To continue the studies 
about AcrB oligomerization, I used FRET to investigate the association of AcrB monomers. 
Two AcrB fusion proteins AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet were constructed. 
Activity assay showed that fusion of CFP or YPet did not change the stability of AcrB. 
Longer linker between AcrB and fluorescent protein could increase FRET efficiency, but 
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decrease expression level. Association of AcrB monomers occurred immediately when 
separately purified monomers were mixed together. Kinetic studies showed that the 
association of AcrB monomers was strongly cooperative. Reconstitution of AcrB 
monomers in liposome revealed that association occurred more readily with lipids in the 
environment.  
 
4.2 Materials and Methods 
4.2.1 Construction of pBAD33-acrB-5aa-CFP, pBAD33-acrB-5aa-YFP, pBAD33-acrB-
15aa-CFP and pBAD33-acrB-15aa-YFP. 
The gene CFP or YFP was inserted into the plasmid pBAD33-acrB using restriction 
enzyme cutting sites XhoI and HindIII and the DNA sequence was confirmed by DNA 
sequencing. The primers used for the construction of AcrB-5aa-CFP and AcrB-5aa-YFP 
are the following:  
For AcrB-5aa-CFP:  
Forward: GAACCGCTCGAGGGAGGATCAGGAGGAATGGTGAGCAAGGGCGAG 
(45 bp)  
Reverse:    
CAACCC AAGCTT ATGATGATGATGATGATG GATCCCGGCGGCGGTCAC (48 bp) 
For AcrB-5aa-YFP:     
Forward 5’-3’: 
GAACCGCTCGAGGGAGGATCAGGAGGAATGTCCGCTTTCTGGTATGCC (48 bp) 
Reverse:  
CAACCC AAGCTT ATGATGATGATGATGATG GATCCCGGCGGCGGTCAC (48 bp) 
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The primers used to elongate the linker are:  
Forward primer: GAT CAT CAT CTC GAG GGT GGT TCT GGT GGT TCT GGT GGT 
TCT GGA GGA TCA GGA GG  
Reverse primer: CC TCC TGA TCC TCC AGA ACC ACC AGA ACC ACC AGA ACC 
ACC CTC GAG ATG ATG ATC 
 
4.2.2 Protein expression and purification 
The plasmids encoding AcrB-5aa-CFP, AcrB-5aa-YFP, AcrB-5aa-YPet or AcrB-15aa-CFP, 
AcrB-15aa-YFP were transformed into E. coli strain BW25113 ΔacrB competent cells. 
Single colony was picked from the LB agar plate and inoculated into tubes, then transferred 
into larger flask containing fresh LB with relative antibiotics. After incubated at 28 oC for 
24 hours, the bacteria cells were harvested and stored in -80 oC freezer before purification. 
The purification protocol was described in 2.2.1 with minor modification. 2 L of fresh LB 
medium containing relative antibiotic was used to culture the strain. 0.2% arabinose was 
added in the culture to induce the synthesis when OD600 reached 1.0. After sonication, 2% 
triton was mixed with cell debris and incubated at 4 oC for 12 hours. 5 mM imidazole was 
used in binding of Ni-NTA beads to sample and 25 mM imidazole was used in wash buffer. 
 
4.2.3 BN-PAGE 
BN-PAGE was conducted as described with minor modifications.161 Briefly, the purified 
AcrB samples were mixed with blue native loading buffer with a final concentration of 0.5 
M 6-aminohexanoic acid, 5% coomassie blue G-250, 5% glycerol, pH 7.0, and loaded to a 
4-20% gradient polyacrylamide gel (BIO-RAD, Hercules, CA). The electrophoresis was 
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performed using the cathode buffer (50 mM tricine, 7.5 mM imidazoole, 0.02% Coomassie 
brilliant blue G-250, pH 7.0) and anode buffer (25 mM imidazole, pH 7.0) at 15 mA, in the 
4°C refrigerator for 2~4 hours. The protein bands were finally visualized after Coomassie 
Blue staining and de-staining. 
 
4.2.4 Drug susceptibility assay 
AcrB activity was usually determined by a drug susceptibility assay. The MIC of different 
stains were measured as described.162 Briefly, an acrB deficient E. coli strain 
(BW25113ΔacrB) was used as the host cell. BW25113ΔacrB strain transformed with 
plasmid-encoded WT-AcrB or pQE70 vector were used as the positive and negative 
controls, respectively. Plasmids encoding different AcrB mutants were transformed into 
BW25113ΔacrB as well. Freshly transformed cells were plated on LB-agarose plates 
containing 100 μg/mL ampicillin and 50 μg/mL kanamycin. The same ampicillin and 
kanamycin concentrations were used throughout the study when noted. A single colony 
was inoculated into a LB media supplemented with ampicillin and kanamycin. The 
exponential-phase cultures of different strains were diluted to an OD600nm of 0.1 with LB 
broth. 10 μL of this diluted culture was used to inoculate into 1 mL LB media containing 
the indicated concentration of erythromycin or novobiocin. The cultures were incubated 
under shaking at 37oC for 6 hours. Absorbance at 600 nm of each culture was measured. 
This activity assay was conducted under the basal AcrB expression condition, which was 
not supplemented with inducer. Each experiment was repeated at least three times. 
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4.2.5 Kinetic studies of AcrB association 
Protein concentration for AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet were estimated 
using UV/vis and SDS-PAGE. Freshly purified AcrBP223G-5aa-CFP and AcrBP223G-5aa-
YPet of different concentration were mixed according to molar ratio of 1:1 when the 
concentration of each protein was determined using the standard curves. Fluorescence 
intensity over time was recorded and initial rate was calculated to determine the association 
constant.  
 
4.2.6 Reconstitution of AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet in liposome.  
Reconstitute the fusion proteins into liposomes was conducted following a protocol in 
literature.163 Briefly, E. coli polar lipid dissolved in chloroform was dried in a glass vial 
under a gentle stream of N2 and then incubated in a vacuum oven at 25 oC overnight. To 
make liposome, sodium phosphate buffer (pH 7.5) was added into the glass vial to reach a 
final concentration of 20 mg/mL. The solution was sonicated on ice for 50 minutes until 
an opaque solution was obtained.  Freshly purified AcrB-5aa-CFP or AcrB-5aa-YPet in pH 
7.5 phosphate buffer with 0.03% (w/v) DDM was mixed with 4% Triton and lipids on a 
shaker at room temperature for 0.5 hour. To remove detergent, Bio-beads pretreated with 
methanol and deionized water was added at a concentration of 40 mg per mL of sample. 
The sample was incubated for 4 hours, and then Bio-beads was removed after 
centrifugation. The supernatant contains liposomes was used to investigate the 
trimerization behavior of AcrB.  
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4.3 Results  
4.3.1 Construction of pBAD33-acrB-5aa-CFP and pBAD33-acrB-5aa-YFP.  
To investigate association of AcrB monomers, fluorescent proteins were fused to AcrB as 
indicators to yield FRET signals. The strategy is to insert CFP or YFP with His6 tag between 
restriction enzyme cutting site XhoI and HindIII (Figure 4.2, A). A linker of 5 amino acids 
“GGSGG” was added between AcrB and CFP or YFP to avoid the influence on AcrB 
folding. As shown in Figure 4.2 B, both AcrB-5aa-CFP and AcrB-5aa-YFP had comparable 
expression levels as WT-AcrB. Analyzed through fluorescence spectrometer with 
excitation wavelength of 435 nm and 514 nm, the two proteins showed emission spectra 
with peaks of 478 nm and 527 nm (Figure 4.2, C and D) which are signature spectra of 
CFP and YFP, respectively. The result revealed that the constructs of AcrB-5aa-CFP and 
AcrB-5aa-YFP expressed well and could be purified.  
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Figure 4.2 Construction of AcrB-5aa-CFP or AcrB-5aa-YFP. A. Plasmid map showing how 
to create the plasmid construct. B. SDS-PAGE (on the top) and Western blot (on the bottom) 
results. C. Fluorescence wavelength scan of AcrB-5aa-CFP, excited at 435 nm. D. 
Fluorescence wavelength scan of AcrB-5aa-YFP, excited at 514 nm.  
 
4.3.2 Influence of longer linker insertion on expression and fluorescence 
To investigate if a longer linker influenced fluorescence of CFP or YFP and FRET between 
them, a 15-amino acid linker with the sequence of “GGSGGSGGSGGSGGG” was inserted 
into gene sequence between acrB and CFP or YFP using Quikchange sited directed 
mutagenesis kit with pBAD33-acrB-5aa-CFP and pBAD33-acrB-5aa-YFP as templates, 
respectively. The same number of bacteria cells were harvested followed by purification of 
AcrB-15aa-CFP or AcrB-15aa-YFP using standard protocol as described in Chapter 2. 
Both proteins showed comparable expression levels and purities according to the results of 
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SDS-PAGE and Western blot (Figure 4.3, A). Fluorescence wavelength scan results 
suggested that both proteins had signature spectra of CFP and YFP (Figure 4.3, B), 
respectively. Whether the longer linker had influence on fluorescence and FRET efficiency 
was determined in the following experiments.  
 
Figure 4.3 Construction of AcrB-15aa-CFP and AcrB-15aa-YFP. A. SDS-PAGE (Top 
picture) and Western blot (bottom piture, anti-whole AcrB antibody was used) analysis of 
AcrB-15aa-CFP and AcrB-15aa-YFP. B. Fluorescence analysis of the two proteins.  
 
4.3.3 Activity of AcrB fusion proteins containing CFP or YFP 
Fusion of fluorescent proteins may influence the activity or stability of target proteins. To 
evaluate the activity of AcrB in all the constructs, MIC test was conducted according to the 
literature.164 The resistance to two AcrB substrates novobiocin and erythromycin of the 
bacteria cells containing plasmid vector encoding different protein constructs were 
determined, while the bacteria cells with acrB gene knocked out was used as negative 
control. All constructs showed comparable MIC values as WT-AcrB (Table 4.1), 
suggesting that the fusion of CFP or YFP to AcrB did not influence the efflux activity of 
AcrB.  
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Table 4.1 MIC of BW25113ΔacrB containing plasmids encoding indicated AcrB constructs.  
Strain 
MIC (μg/mL) 
Novobiocin Erythromycin 
WT-AcrB 320 160 
AcrB-5aa-CFP 320 160 
AcrB-5aa-YFP 320 80 
AcrB-15aa-CFP 320 160 
AcrB-15aa-YFP 320 80 
AcrB-5aa-YPet 320 80 
ΔacrB 20 20 
 
 
4.3.4 Co-expression of AcrB constructs in vivo.  
AcrB is biosynthesized, folded and oligomerized in bacteria cells, so it is important to 
observe if there is FRET in AcrB trimers in vivo. The strategy was that two compatible 
plasmids harboring acrB-CFP and acrB-YFP genes were co-transformed and expressed in 
the same competent cells. In theory, AcrB monomers with fluorescent proteins associated 
into AcrB trimers in which only CFP and YFP fused hetero-trimers showed FRET signal. 
Here the plasmid vector pBAD18, compatible with pBAD33, was used to harbor gene acrB-
5aa-YFP or acrB-15aa-YFP. And the CFP fusions were inserted in the plasmid pBAD33. 
Monomers of AcrB-5aa-CFP, AcrB-5aa-YFP, AcrB-15aa-CFP, and AcrB-15aa-YFP were 
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synthesized in bacteria cells and associated into trimers so that FRET occurred between 
CFP and YFP. To calculate FRET efficiency, the equation E = 1 −
𝐹𝐷
𝐹𝐷𝐴
 was used where E 
indicates FRET efficiency, FD and FDA indicate fluorescence intensities for donor 
fluorophore in absence and in presence of acceptor fluorophore, respectively. Since both 
AcrB-5aa-CFP and AcrB-5aa-YFP were biosynthesized in vivo, an external standard curve 
for concentration versus fluorescence was determined. The result (Figure 4.4, B) showed 
that co-expressed AcrB-15aa-CFP/YFP trimers had higher FRET efficiency than co-
expressed AcrB-5aa-CFP/YFP trimers. A possible explanation for higher FRET efficiency 
was that longer linker made CFP and YFP more flexible to increase the opportunities to 
interact. Another possible explanation was that longer linker improved the orientation 
preference for FRET occurrence.  However, the expression level of AcrB-15aa-YFP was 
much lower than that of AcrB-5aa-YFP (Figure 4.7 A, Figure 4.2 A and Figure 4.3 A), 
which was not suitable for the following experiments, such as kinetic studies in which 
series dilution would be conducted. Therefore, 5aa linker would be used in the following 
experiments.  
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Figure 4.4 Co-expression of AcrB-5aa-CFP/YFP and AcrB-15aa-CFP/YFP. A. SDS-PAGE 
analysis of co-expressed samples. B. FRET efficiency calculation. C. Fluorescence 
wavelength scan of co-expressed AcrB-5aa-CFP/YFP. D. Fluorescence wavelength scan of 
AcrB-15aa-CFP/YFP.  
 
4.3.5 Mutation P223G was used to create AcrB monomers  
Previous studies showed that Pro223 was critical for the stability of AcrB trimers and 
mutation Pro223Gly made most of AcrB trimers dissociate into AcrB monomers when they 
were freshly purified. CD analysis and thermal stability studies revealed that P223G did 
not change the secondary structure and monomer stability, although it disrupted the trimer 
and caused the whole AcrB efflux pump non-functional.165 An interesting finding is that 
part of AcrB monomers re-associated into AcrB trimers when elution fractions were 
dialyzed in PBS buffer containing 0.03% DDM, which made the observation of AcrB 
monomers’ association possible. In this study, P223G was introduced to create AcrB 
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monomers and dialysis was used for the monomers to form trimers. FRET between CFP 
and YFP was used to monitor the association. (Figure 4.5, B). Obviously, the mixed sample 
showed a FRET bump after dialysis and calculation result showed the FRET efficiency was 
~0.13, which is lower than co-expressed AcrB-5aa-CFP/YFP in cells.  
 
Figure 4.5 Association of AcrBP223G monomers. A. SDS-PAGE analysis of freshly purified 
proteins. B. Fluorescence wavelength scan of mixed AcrBP223G-5aa-CFP and AcrBP223G-
5aa-YFP monomers before and after dialysis.  
 
BN-PAGE was firstly developed for purification of mitochondrial membrane protein 
whose molecular weight was between10 kDa to 10 MDa.161 Later, BN-PAGE was used to 
analyze the native masses and oligomeric states of proteins clinically. In this study, BN-
PAGE was used to analyze the native states of AcrB fusion proteins before and after 
dialysis. Before dialysis, most proteins existed as monomers (as shown in Figure 4.6). After 
dialysis, AcrB monomers formed into trimers and reached equilibrium so that some trimers 
were observed in the BN-PAGE gel. Band intensities of trimers and monomers were 
calculated through ImageJ. The result showed that the percentage of trimers was 41% after 
dialysis, comparing to <5% before dialysis.  
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Figure 4.6 BN-PAGE analysis of purified proteins and mixture before and after dialysis.  
 
4.3.7 Co-expression of AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet.  
Although the FRET efficiency of co-expressed AcrB-15aa-CFP/YFP was higher than co-
expressed AcrB-5aa-CFP/YFP, expression level of AcrB-15aa-YFP was not high enough 
for the following experiments, especially for the kinetic studies. In addition, FRET 
efficiency for mixed AcrBP223G-5aa-CFP/YFP in vitro was not high, possibly resulted from 
the low expression level of AcrB-5aa-YFP and low quantum yield of YFP. To increase the 
FRET intensity as well as FRET efficiency, YPet was introduced to substitute YFP. YPet, 
an improved version of YFP, is much brighter than YFP and has excellent photostability.166 
SDS-PAGE result (Figure 4.7, A) showed that the expression level of AcrBP223G-5aa-YPet 
was much higher than that of AcrBP223G-5aa-YFP. Comparing the FRET efficiency of 
mixed AcrBP223G-5aa-CFP/YFP (~0.13), FRET efficiency of mixed AcrBP223G-5aa-
CFP/YPet increased to ~0.34 (Figure 4.7, B). Fluorescence wavelength scan result also 
revealed that the FRET bump was much higher for CFP/YPet mixture than CFP/YFP 
mixture (Figure 4.7 D and Figure 4.5 B). Another interesting result is that FRET efficiency 
of mixed purified samples (~0.34) was higher than that (~0.22) of co-expressed sample 
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(Figure 4.7, C and D). A possible explanation is the molar ratio of CFP/YPet is not 1 to 1 
in vivo, while the molar ratio in vitro was set as 1 to 1 which could maximize the FRET 
efficiency between them. 
 
Figure 4.7 Association of AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet monomers. A. SDS-
PAGE analysis of purified proteins. B. FRET efficiency calculation. C. Fluorescence 
spectra of co-expressed AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet before and after 
dialysis. D. Fluorescence spectra of mixed AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet 
before and after dialysis. 
 
BN-PAGE was conducted to determine the percentage of AcrB monomers and trimers 
before and after dialysis. The results (Figure 4.8) showed that freshly purified AcrBP223G-
5aa-CFP and AcrBP223G-5aa-YPet monomers oligomerized into trimer in BN-PAGE when 
90 
 
they were mixed and analyzed. The percentage of trimer formed in electrophoresis was 
about 20%, while it increased to 58% after dialysis which was much higher than mixed 
AcrBP223G-5aa-CFP/YFP (41% after dialysis).     
 
Figure 4.8 BN-PAGE analysis of AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet monomers 
and trimers before and after dialysis.  
 
4.3.8 Association of AcrB monomers occurred immediately when AcrB monomers 
were mixed 
To determine the kinetic properties of AcrB association, 0.1 μM of freshly purified 
AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet were mixed according to molar ratio of 1:1 
without dialysis. Before the assay, the samples were pre-warmed in 25 oC water bath for 5 
minutes. The change of FRET intensity over time was used as a reporter of AcrB 
association. The result (Figure 4.9) showed that FRET signal increased immediately when 
the two samples were mixed, indicating that AcrB association occurred immediately when 
the monomers encountered. It went to plateau after about 6-hour incubation at 25 oC which 
indicated that an equilibrium reached at that time point.   
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Figure 4.9 Fluorescence analysis of mixed AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet 
freshly purified without dialysis. Excitation wavelength is 400 nm while emission 
wavelength is 527nm.  
  
4.3.9 Addition of AcrBP223G inhibited the association of AcrB-5aa-CFP/YPet trimer 
To determine whether non-fluorescent AcrB monomers inhibit the association of 
fluorescent tagged AcrB monomers, freshly purified AcrBP223G were added into the mixture 
when they were mixed at time 0. The result showed FRET signal between AcrBP223G-5aa-
CFP and AcrBP223G-5aa-YPet in the presence of AcrBP223G increased not as fast as the 
samples in the absence of AcrBP223G (as shown in Figure 4.10, A). After incubation at 4 oC 
overnight, the FRET bump of AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet mixture with 
AcrBP223G was not as high as the samples without AcrBP223G (as shown in Figure 4.10, B). 
Both results suggested that AcrBP223G participated in association which competed with 
other monomers with fluorescent protein, so that it inhibited the association of AcrBP223G-
5aa-CFP and AcrBP223G-5aa-YPet monomers.  
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Figure 4.10 Inhibition of AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet association by 
addition of AcrBP223G monomers. A. The change of FRET intensity over time. B. 
Fluorescence wavelength scan of mixed AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet with 
or without AcrBP223G after 24-hour incubation. 
 
4.3.10 Kinetic studies of AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet monomer 
association 
To characterize the association, kinetic studies were conducted as described in methods. 
AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet monomers with different initial concentration 
obtained by a series of dilution were mixed according to molar ratio of 1:1. The change of 
FRET signal intensity over time was monitored using the spectrometer. Plotting FRET 
intensities on y axis and time on x axis, a linear curve was obtained and the slope (the unit 
is au/s) indicated the relationship between fluorescence change and time. To calculate the 
initial rate of the reactions, fluorescence intensities of AcrB-5aa-CFP samples with 
different concentrations were used to make a linear standard curve and its slope (the unit 
is au/μM) indicated the relationship between fluorescence intensity and concentration. The 
first slope (au/s) divided by the second slope (au/μM) was used to obtain the initial rate.  
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Initial reaction rate with unit of μM/s versus substrate concentration with unit of μM were 
used to plot the data. The Hill equation as shown in the following which was used to 
determine cooperativity. The result (Figure 4.11) showed that in association, maximum 
reaction rate (Vmax) was 0.24 ± 0.02 μM/s, Hill coefficient “n” was 3.13 ± 0.80, and K0.5 
was 0.37 ± 0.04 μM.  The positive value of n suggested a positive cooperativity among 
monomers’ association into trimers. The value of K0.5 reflects AcrB trimer affinity, while 
Vmax revealed how fast the trimers formed.  
v =
𝑉max[𝑠]
𝑛
𝐾0.5
𝑛 + [𝑠]𝑛
 
where v represents reaction velocity, [S] represents substrate concentration, K0.5 represents 
half maximal concentration constant.167  
 
 
Figure 4.11 Kinetic studies of AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet.  
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4.3.11 Characterization of the interaction of AcrBP223G-5aa-CFP and AcrBP223G-5aa-
YPet in lipid bilayers.  
To mimic AcrB association in cell membrane environment, reconstitution of AcrBP223G-
5aa-CFP and AcrBP223G-5aa-YPet in liposome was conducted using E.coli polar lipid. The 
result (Figure 4.12) showed that association in liposome (~1.5 hours) is faster than in 
detergent (~2 hours). And FRET efficiency for the association in liposome (~0.1) was much 
higher than in detergent (~0.03). It suggested that liposome is more favorable for AcrB 
monomers to associate, comparing to the detergent micelles.   
 
Figure 4.12 Reconstitution of AcrBP223G-5aa-CFP and AcrBP223G-5aa-YPet in liposome. A. 
Change of FRET intensity over time. B. Fluorescence wavelength scan of mixture 
incubated in liposome and DDM for 5 hours.   
 
4.4 Discussion and Conclusion  
It is difficult to determine the kinetic behavior of RND pumps, because the complex spans 
cytoplasm, periplasm, and two membranes. Another reason is there are three components 
in the complex, it is uncertain if the kinetic properties are determined from one single 
component or from the whole complex.168 To date, there are not many reports about the 
oligomerization of RND pumps, especially for AcrB, although the crystal structures of 
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them have been resolved.  FRET is a powerful method that can be used to study biological 
kinetic process. In most cases, fusion of fluorescent proteins does not change the structure 
and the function of the proteins studied and the sensitivity of fluorescence is relatively 
higher than many other traditional biochemistry techniques. Conformational change could 
be reflected by FRET like a switch with on state and off state. Therefore, FRET is 
appropriate approach to study the association of AcrB monomers.  
 
FRET efficiency which depends on separation distance between donor and acceptor with a 
reversed 6-th power law provides some insights about the distance among protein subunits 
in this study. Higher FRET efficiency usually indicates shorter distance between donor and 
acceptor which is helpful for kinetic studies.60 To obtain high FRET efficiency, different 
linker and different fluorescent protein combination were tried. 15aa linker constructs had 
lower expression level, which is not suitable for further studies. Comparing to YFP, YPet 
is a better FRET partner for CFP. YPet with brightness value of 238 (product of extinction 
coefficient and quantum yield, expressed as a percentage of EGFP) is much brighter than 
YFP which has a brightness value of 151. In addition, the quantum yield of YPet (0.77) is 
higher than YFP (0.61).169 Both factors determine that FRET efficiency for CFP-YPet pair 
is higher than CFP-YFP pair, and expression level of YPet was much higher. Kinetic studies 
showed a Hill coefficient value greater than 1 which suggested that positive cooperativity 
in association of AcrB monomers. It indicated that association of AcrB monomers into 
dimers possibly facilitated the third monomer to bind, which provided some insight about 
how AcrB trimers formed. Comparing to the association of trimer from three monomers 
simultaneously, it seemed that forming dimers first was more reasonable. Association of 
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AcrBP223G monomers in vitro occurred immediately when the monomers were mixed, 
which indicated that the association rate was really fast. Half maximal concentration 
constant showed AcrB affinity is high. Reconstitution result showed that the presence of 
lipids and formation of liposome is better for association of AcrB monomers than DDM. 
The possible explanation is that the presence of fragments of lipid bilayers during and after 
the formation of liposomes provide a more favorable environment for AcrB monomers to 
interact and association.   
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Chapter Ⅴ. Application of Fluorescence Protein in Kinetic Studies of ssrA-tagged 
Membrane Protein Degradation 
 
5.1 Introduction 
Removing extraneous or damaged protein through protein degradation is critical for cells 
to function fundamentally. In eukaryotic organisms, there are mainly two important 
proteolytic machineries: the proteasome and lysosome which are responsible for protein 
degradation in the ubiquitin-proteasome system and autophagy, respectively.170 Most 
studies showed that misfolded membrane protein is dislocated through the endoplasmic 
reticulum associated degradation (ERAD) pathway, followed by ubiquitination and 
subsequent degradation by proteasome. An alternative strategy involves proteases cleaving 
their substrates in the plane of membrane instead of pulling out transmembrane domain of 
substrates from the membrane.171 In prokaryotic cells, there are mainly two types of 
proteases which recognize the substrates and translocate them into core compartment for 
degradation. One type is degradation complexes such as ClpXP, ClpAP, FtsH, while the 
other type is proteasome ubiquitin-like proteins like Pup and SAMPs.75 Similar to ubiquitin 
in eukaryotes, prokaryotic ubiquitin-like protein does a similar work in Archaea and some 
bacteria. Prokaryotic ubiquitin-like protein was first discovered in 2008 and named “Pup”. 
Later, SAMPs indicating ubiquitin-like small archaeal modifier proteins with other related 
enzymes were identified in Haloferax volcanii.172 For degradation complexes, N-end rule 
recognition applies in a lot of families, but ClpXP and ClpAP recognize a C-terminal 
signature peptide called “ssrA” with an amino acid sequence of “AANDENYALAA”. 
ClpXP system belongs to AAA+ protease, which plays a critical role in degradation of ssrA 
tagged protein in almost all species. However, it is a challenge to understand how 
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prokaryotic cells degrade membrane proteins, although degradation of soluble proteins has 
been well studied. In E.coli cells, tm RNA or SsrA ribosome rescue system mediates 
addition of ssrA tag to nascent peptide in protein biosynthesis when ribosome stalls. Then 
proteases such as ClpXP, ClpAP or FtsH degrade the ssrA tagged protein.173  
 
To expand the use of GFP as reporter, GFP-ssrA and its variants were firstly constructed 
by Jens Bo Anderson et al in 1998.174 Soon GFP-ssrA, whose conformation change could 
be monitored in fluorescence and absorption, became a good model substrate of ClpXP or 
ClpAP to study the mechanism of degradation and even the dynamics in Dr. Sauer’s lab 
and Dr. Baker’s lab.175 Degradation of ssrA-tagged protein is a multistep reaction including 
five steps: binding of substrates to ClpXP, substrate denaturation, translocation,  substrate 
cleavage and release of peptide fragments. Among them, substrate denaturation limits the 
overall degradation rate according to the kinetic studies in which 35S labelled GFP peptides 
were used as indicators. 175 Adaptor protein SspB enhances the degradation of ssrA tagged 
protein by helping to bring substrates and ClpXP together. In absence of SspB, degradation 
of GFP-ssrA showed a Vmax of 0.9 min-1ClpX-1 while the value is 1.2 min-1ClpX-1 in 
presence of GFP-ssrA.176  
 
Analyzing data collected from the experiments is always an important step in research. 
Michaelis-Menten kinetics, shown in the following, which was derived in 1913 and named 
after German biochemist Leonor Michaelis and Canadian physician Maud Menten is one 
of the best-known approaches to enzyme kinetics.177 In 1925, Briggs and Haldane 
interpreted Michaelis-Menten kinetics and assumed the reaction reaches a state called 
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quasi-steady state in which enzyme-substrate complex remains constant when the 
concentration of substrates is much higher than that of enzyme.178  
v =
𝑑[𝑃]
𝑑𝑡
=
𝑉max[𝑆]
𝐾𝑀 + [𝑆]
 
where KM represents Michaelis constant, Vmax represents the maximum velocity the system 
achieved, v represents the reaction rate and [S] represents initial substrate concentration. 
Besides Michaelis-Menten kinetics, the Hill equation is another important approach to 
enzyme kinetics. The Hill equation as shown in the following, firstly formulated and 
applied by Archibald Vivian Hill to describe the binding of oxygen to haemoglobin which 
showed a sigmoidal curve in 1913, has been extensively used in biochemistry, physiology 
and pharmacology to analyze the interactions between ligands and receptors.179; 180  
θ =
𝐵𝑜𝑢𝑛𝑑
𝑇𝑜𝑡𝑎𝑙
=
[𝐿]𝑛
𝐾𝑑 + [𝐿]
𝑛 
=
[𝐿]𝑛
(𝐾𝐴)
𝑛 + [𝐿]𝑛
=
1
(
𝐾𝐴
[𝐿]
)
𝑛
+ 1
 
where θ represents fraction of the receptor protein concentration that bound to ligands. [L] 
represents the concentration of unbound ligands. Kd represents apparent dissociation 
constant.180 The derivation of Hill equation used in enzyme kinetics is following: 
v =
𝑉max[𝑠]
𝑛
𝐾0.5
𝑛 + [𝑠]𝑛
 
where v represents reaction velocity, [S] represents substrate concentration, K0.5 or Khalf 
half maximal concentration constant. Hill coefficient “n” is not equal to the number of 
binding sites, and it tends to the number of binding sites when the cooperativity is strong.167  
 
Previous studies in our lab showed that ssrA tag facilitated the degradation of AcrB.181 
Deletion of clpX or clpP gene increased the expression of AcrB-ssrA, indicating that ClpXP 
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was involved in the degradation of AcrB-ssrA in vivo. Co-transformation experiment and 
ethidium bromide efflux assay showed that AcrB-ssrA was degraded after membrane 
insertion. To quantitatively monitor the kinetics of degradation, a real-time assay is 
essential. In early studies, we created several AcrB-fluorescent protein fusions and 
confirmed that the fusion proteins are fully active.  Here we used AcrB-CFP to investigate 
its degradation. Monitored using fluorescence spectrometer, the degradation of AcrB-CFP-
ssrA showed a lower degradation rate comparing to the degradation of GFP-ssrA. SspB 
improved the degradation rate drastically.  
 
5.2 Material and methods 
5.2.1 Cloning, Expression and Purification of AcrB-15aa-CFP-ssrA.  
The plasmid pFLIPmal-40uDelta1YFP (plasmid catalog number 18853) harboring CFP 
gene was purchased from Addgene (Cambridge, MA). Primers encoding 15 amino acid 
linker GGSGGSGGSGGSGGS and ssrA tag were ordered from Integrated DNA 
technologies (Coralville, IA). To fuse CFP with AcrB, the restriction enzyme cutting sites 
XhoI and HindIII in plasmid vector pBAD33 were applied in digestion and ligation. After 
DNA sequencing, the plasmid pBAD33-acrB-15aa-cfp-ssrA was transformed into E.coli 
DL41ΔacrBΔclpX (Kanamycin cassette removed, DE3) competent cells for expression and 
purification. Purification of AcrB-15aa-CFP-ssrA were conducted as described.39 
 
5.2.2 Degradation of AcrB-CFP-ssrA by ClpXP system In vivo and In vitro.  
In vivo, the plasmid pBAD33-acrB-15aa-CFP-ssrA or pBAD33-acrB-15aa-CFP was 
transformed into DL41 or DL41ΔclpX competent cells separately. Single colonies were 
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picked from LB agar plates and cultured into tubes containing LB medium and relative 
antibiotics at 37oC overnight. Cell pellet after sonication and centrifugation was dissolved 
in 10% SDS and then incubated at room temperature for 10 min. Supernatant was analyzed 
through SDS-PAGE and Western blot. To confirm the result of In vivo assay, the plasmids 
pBAD33-acrB-15aa-cfp-ssrA and pET28a-his6-clpX were co-transformed in DL41ΔacrB 
ΔclpX (Kanamycin cassette removed, DE3) competent cells. The synthesis of ClpX was 
induced by 0.25 mM IPTG when OD600 of the cells reached ~1.0. At time 0, 2.5, 5, 10, 20, 
30 min, take out the same amount of the cells and harvest the cells using centrifugation of 
7000 rpm, 3min. SDS-PAGE and Western blot were used to analyze left AcrB-CFP-ssrA 
after degradation.  
 
In vitro, purified protein substrate was mixed with ClpX, ClpP and SspB according to 
specific molecular ratio according to different protein substrates in PD buffer containing 
0.03% DDM which was incubated in ice bath before the assay. 5mM ATP with ATP 
regeneration system containing 16mM creatine phosphate and 0.32 mg/mL creatine kinase 
was added into the system to provide energy for proteases. Then the mixture was 
transferred into 30 oC water bath for incubation. LS 55 fluorescence spectrometer was used 
to monitor the change of fluorescence intensity over time. At time 0, 2.5, 5, 10, 20 and 30 
min, 30 uL of the mixture was collected and mixed with 4 uL of 6* SDS loading dye 
containing 100 mM PMSF to stop the reaction. Western blot was conducted to determine 
the amount of substrate leftover.  
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5.2.3 Protein stability assay of AcrB-CFP-ssrA and related mutants.  
Drug susceptibility of the cells harboring the gene acrB-cfp-ssrA and related variants was 
determined by measuring minimum inhibitory concentration (MIC) of erythromycin and 
novobiocin. The strains were cultured overnight and then diluted in 10-fold as the starting 
culture, and then they were added into 1mL LB medium containing two-fold diluted 
antibiotic. All the cells were incubated at 37oC for 6 hours, absorbance of the cultured was 
measured by BioTek Gen5 reader.   
 
The stability of AcrB-CFP-ssrA and relative variants were also determined by the limited 
trypsin digestion. Trypsin (Sigma-Aldrich, St. Louis, MO) was mixed with WT-AcrB or 
AcrB-CFP-ssrA with the molecular ratio of 1:30 in buffer (20 mM sodium-phosphate, 200 
mM NaCl, 10% glycerol, 0.03% DDM, pH 7.5) at room temperature. At the indicated time 
point, digestion was quenched by the addition of 6 ×SDS protein loading dye and PMSF. 
The samples were resolved through Western blot. 
 
5.2.4 Kinetic studies of AcrB-CFP-ssrA degradation by ClpXP SspB system.  
All proteins used in the assay were freshly purified using the protocol described in the 
previous chapter. The degradation assay was conducted according to the reference with 
minor modification.175 All the solutions and samples used in the assay were pre-warmed in 
30 oC water bath for 2 minutes. Substrate with different concentration was added after the 
spectrometer reading reached equilibrium.  Data fitting was conducted in OriginLab 9.0. 
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5.3 Results  
5.3.1 Expression level determination of AcrB-CFP-ssrA in different competent cells.  
In the previous studies, plasmid encoding acrB-ssrA was transformed into different 
competent cells with clpX, clpA, clpP and sspB knocked out. AcrB-ssrA expression could 
be observed in ΔclpX and ΔclpP cells, indicating ClpX and ClpP played a critical role in 
degradation of AcrB-ssrA. In this study, CFP was used as an indicator to monitor the 
degradation of AcrB-ssrA, which is more accurate than Western blot, especially in kinetic 
studies. To determine whether AcrB-CFP-ssrA was degraded in vivo, the plasmid pBAD33-
acrB-CFP-ssrA was transformed into DL41ΔacrB and DL41ΔacrBΔclpX competent cells 
respectively. Clearly, Western blot result (Figure 5.1) showed that AcrB-CFP-ssrA was well 
expressed in DL41ΔacrBΔclpX cells while it was not in DL41ΔacrB, indicating that ClpX 
played a critical role in the degradation and removing clpX gene increased the expression 
of AcrB-CFP-ssrA.  
 
Figure 5.1 Expression level determination of AcrB-CFP-ssrA in DL41ΔacrB and 
DL41ΔacrBΔclpX competent cells.  
 
Membrane proteins need to be translocated and inserted into cell membrane by signal 
recognition particle and chaperone proteins when they are synthesized in ribosome.182 To 
determine whether AcrB was degraded after insertion into inner membrane, the plasmid 
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pBAD33-acrB-CFP-ssrA was co-transformed into DL41ΔacrBΔclpX (Kanamycin cassette 
removed, DE3) competent cells with pET28a-clpX. Expression of AcrB-CFP-ssrA did not 
need induction, while biosynthesis of ClpX was induced with 1 mM IPTG when OD600 
reached 0.8. The result of Western blot (Figure 5.2) showed that all AcrB-CFP-ssrA 
expressed was degraded in 10 minutes, which was consistent with the result of expression 
level determination. The degradation rate was similar as the degradation rates of AcrB-ssrA 
and GFP-ssrA, which were obtained using radioactive method.176; 181  
 
Figure 5.2 Co-expression of AcrB-CFP-ssrA and ClpX. 
 
5.3.2 Activity and stability assay of ssrA tagged AcrB constructs 
MIC test result showed that addition of CFP and ssrA tag did not influence the efflux 
activity of AcrB (Table 5.1). An alternative way to determine protein stability is limited 
trypsin digestion. Trypsin is a serine protease which catalyze the hydrolysis of protein 
peptides into small pieces at the carboxyl side of arginine or lysine.183 To compare the 
stability of AcrB-CFP with WT-AcrB, limited trypsin digestion was conducted (Figure 5.3). 
Both protein substrates were resistant to trypsin digestion in 30 minutes and the way the 
two proteins were digested were similar, indicating that AcrB-CFP had similar 
conformation as WT-AcrB and fusion of CFP did not change the stability of AcrB.  
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Table 5.1 MIC test of AcrB-CFP-ssrA. 
Strain 
MIC (μg/mL) 
Erythromycin Novobiocin 
WT-AcrB 160 320 
AcrB-CFP-ssrA 160 320 
ΔacrB 10 20 
 
 
 
Figure 5.3 Limited trypsin digestion of purified WT-AcrB and AcrB-CFP. 
 
5.3.3 Degradation of AcrB-CFP-ssrA by ClpXP with or without SspB 
SspB is a dimeric substrate adaptor aids in delivery of ssrA-tagged substrates to ClpXP 
degradation system. The effect of the adaptor in the degradation of AcrB-CFP-ssrA was 
determined by comparing the degradation rate with or without SspB. The molecular ratio 
of AcrB-CFP-ssrA to SspB was set as 1 to 1. Obviously, the degradation rate was much 
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faster in the presence of SspB. The role of SspB played in the degradation process was 
aiding the binding of the substrate with ClpX.  
 
 
Figure 5.4 Degradation of AcrB-CFP-ssrA in presence or in absence of SspB. 
 
5.3.4 Degradation of freshly purified AcrB-CFP-ssrA by ClpXP SspB In vitro.  
AcrB-CFP-ssrA was freshly purified with high enough purity for degradation assay. After 
dialysis, the protein substrate was degraded by ClpXP system with a molar ratio of 1: 3: 6: 
1 for AcrB-CFP-ssrA to ClpX, ClpP and SspB. Similar to the degradation of AcrB-CFP-
ssrA in vivo which was fully degraded in 10 min, the degradation in vitro showed that more 
than 80 percent of the protein substrates were degraded in the first 10 minutes (Figure 5.5, 
B and C), although the protein substrate was not fully degraded. To determine if AcrB was 
degraded by the system, FLAG tag was inserted before CFP and AcrB, respectively. 
Western blot result showed that both AcrB and CFP were fully degraded by ClpXP (Figure 
5.5, C and D). 
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Figure 5.5 Degradation of purified AcrB-FLAG-CFP-ssrA by ClpX, ClpP, SspB In vitro. 
A. Determined by fluorescence spectrometer. B. Loss percentage calculation of AcrB-CFP-
ssrA. C. Western blot result showing the degradation of AcrB-CFP-FLAG-ssrA. Anti-
FLAG-tag antibody was used. D. Western blot result showing the degradation of FLAG-
AcrB-CFP-ssrA and AcrB-FLAG-CFP-ssrA. Anti-FLAG tag antibody was used.  
 
 
5.3.5 Unfolding of AcrB-CFP-ssrA by ClpX 
Interestingly, AcrB-CFP-ssrA could be partially unfolded by ClpX alone while GFP-ssrA 
was unfolded partially in the first several minutes and then refolded back (Figure 5.6). GFP 
is mainly comprised of 11 beta sheets which make GFP a relatively tight structure.64 The 
degradation level was higher and the rate was faster when SspB was added to help 
unfolding in the system.   
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Figure 5.6 Degradation of AcrB-CFP-ssrA and GFP-ssrA. A. Degradation of AcrB-CFP-
ssrA by ClpX alone. B. Degradation of AcrB-CFP-ssrA by ClpXP. C. Degradation of GFP-
ssrA by ClpX alone. D. Degradation of GFP-ssrA by ClpXP.  
 
5.3.6 Kinetic studies of degradation of AcrB-CFP-ssrA. 
Comparing to the degradation of GFP-ssrA, Michaelis-Menten kinetics showed worse 
fitting result than The Hill equation fitting (Figure 5.7). And the maximum velocity of the 
degradation of AcrB-CFP-ssrA is much slower than GFP-ssrA (Table 5.2). However, the 
binding of substrates to enzyme seemed higher for AcrB-CFP-ssrA than GFP-ssrA. The 
Hill equation fit the data of AcrB-CFP-ssrA degradation better than Michaelis-Menten 
kinetics, suggesting the degradation behavior of AcrB-CFP-ssrA might be different from 
GFP-ssrA degradation.  
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Figure 5.7 Kinetic studies of ssrA tagged protein degradation. A. Degradation of GFP-
ssrA. Michaelis-Menten kinetics was used to fit the data. B. Degradation of AcrB-CFP-
ssrA. Michaelis-Menten kinetics and the Hill equation were used to fit the data.  
 
Table 5.2 Michaelis-Menten kinetics and the Hill equation fitting results.  
Parameter 
GFP-ssrA AcrB-CFP-ssA 
Michaelis-Menten 
kinetics fitting 
Michaelis-Menten 
kinetics fitting 
The Hill equation 
fittting 
K (μM) 3.10 ± 0.84 0.296 ± 0.148 0.106 ± 0.009 
Vmax (s-1enz-1) 0.050 ± 0.008 0.016 ± 0.005 0.009 ± 0.001 
R2 0.98 0.86 0.95 
n N/A N/A 3.26 ± 0.75 
 
 
5.4 Discussion and Conclusion 
How misfolded or nonfunctional membrane proteins are removed from E.coli is poorly 
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understood, although the degradation of soluble protein has been well studied. In the 
previous study, degradation of ssrA-tagged AcrB, an inner membrane protein in E.coli, was 
investigated. The result showed that ssrA tagged AcrB was degraded in 15 minutes 
consistent with what was shown through pulse chase experiment. Here we inserted CFP as 
an indicator between AcrB and ssrA tag to create a better method to monitor the degradation 
and determine the kinetic properties of the degradation. The results showed that insertion 
of CFP did not change the activity and stability of AcrB shown through MIC test and 
limited trypsin digestion. The 5-amino acid linker between AcrB and CFP ensured that 
folding of AcrB was not influenced by insertion of CFP. CFP folds tightly when it is 
synthesized, and also the size, only 230 amino acid, is much smaller than AcrB which has 
1049 amino acid with a 15-amino-acid tail at C terminus. Insertion of CFP did not influence 
the degradation of AcrB-ssrA, which could be concluded from the degradation rate 
observed in vivo. In vitro, it seemed that insertion of CFP increased the efficiency of 
degradation, possibly due to improved binding between CFP and ClpX or SspB.  
 
To determine whether the degradation occurred after the insertion of AcrB in the membrane, 
co-expression of AcrB-CFP-ssrA and ClpX was conducted. AcrB was synthesized before 
synthesis of ClpX which need induction of IPTG. Degradation of freshly purified AcrB-
CFP-ssrA provided insights about the roles of ClpX, ClpP and SspB play in the degradation. 
SspB is an adaptor which aids the substrate to bind with ClpX. With the help of SspB, the 
degradation of GFP-ssrA is much faster than the degradation without SspB.176 But it is still 
not clear that whether all the three protein interactions (ClpX •SspB, SspB•ssrA, and 
ssrA•ClpX) occurs simultaneously or only two of them contacts (ClpX•SspB and 
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SspB•ssrA). ClpX unfolds the protein substrates and translocates them to the chamber of 
ClpP, however itself does not have the ability to degrade the unfolded polypeptides into 
small pieces. In both degradation experiments, SspB also contributed to the decrease. As a 
control, the unfolding of GFP-ssrA showed an even more interesting fluorescence change 
in which the fluorescence decreased firstly and then recovered to the original level 
indicating that GFP-ssrA was unfolded and refolded back to original structure. It has been 
reported that GFP has a very tight structure with 11 β-sheets and 1 α-helix which formed a 
structure called β-can. Without the continuous degradation of ClpP, partially unfolded 
GFP-ssrA polypeptides are easily refolded due to the special structure. However, the 
existence of AcrB prevent the refolding in the construct of AcrB-CFP-ssrA so that the 
fluorescence intensity did not recover. ClpP has a chamber by which the unfolded 
polypeptides can be digested into small pieces of several amino acids. In the presence of 
ClpP, both degradation of GFP-ssrA and AcrB-CFP-ssrA reached a final degradation state 
in which over 80 percentage of fluorescence signal was lost due to the expose of 
chromophore in the degradation process.  
 
Another question need to be answered is that did the result of fluorescence decrease reflect 
the degradation of AcrB. The answer is yes. Since there are two components in the 
construct, AcrB and CFP. The fluorescence decrease only reflects the degradation of CFP, 
so FLAG tag was inserted at different positions of the plasmid: before AcrB, between AcrB 
and CFP, and after CFP. Anti-FLAG Western blot was used to monitor the degradation of 
AcrB-CFP-ssrA. The results (Figure5.5, A, C and D) showed that the degradation of AcrB 
over time was consistent with the decrease of fluorescence intensity for all the three 
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constructs with FLAG tag. Therefore, in the following experiments which mainly focus on 
the kinetic studies only used fluorescence as the indicator to show the level of degradation.  
 
The measurement of the initial digestion rate versus substrate concentration yielded a 
sigmoidal plot with a positive Hill coefficient around 3, indicating the substrate binding 
and degradation to one AcrB subunit positively affected the binding and degradation of the 
neighboring subunits. Degradation of AcrB-CFP-ssrA seemed more difficult than the 
degradation of GFP-ssrA as reflected in Vmax, because AcrB has 12 transmembrane α-
helices which make AcrB more stable. Binding of AcrB-CFP-ssrA displayed a tighter 
affinity than GFP-ssrA. This is an interesting observation since the AcrB moiety is far away 
from the initial binding site, the ssrA tag. Several factors may affect the K value, including 
the accurate estimation of the substrate concentration and measurement of the degradation 
rate. Additional experiments will be necessary to validate this initial finding. 
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Appendix --- Miscellaneous Studies  
 
6.1 Application of FRET to study AcrB trimer affinity 
6.1.1 Materials and Method 
AlexaFluor350-Maleimide labelling 
To investigate the application of FRET on AcrB affinity, two mutants AcrBW13C and 
AcrBW13C/P223G were created by sited mutagenesis. Expression and purification was 
conducted as described above. For labeling, freshly purified CL-AcrBW13C or CL-
AcrBW13C/P223G samples were incubated in the dialysis buffer in the presence of a 20-fold 
molar excess of AF350-MLM. The reaction mixture was incubated on ice for 1 h, and then 
Tris-Cl (pH 8.0) was added to a final concentration of 10 mM. Free dye was removed 
through dialysis of twice overnight. The molar ratio of labeling was estimated from the UV 
absorbance of the protein (extinction coefficient of 90 000 cm−1 M−1 at 280 nm) and AF350 
(extinction coefficient of 19 000 cm−1 M−1 at 346 nm). For FRET measurement, the 
excitation wavelength was 280 nm. To determine the contribution of leaky emission of 
AF350 excited at 280 nm, emission spectra of a solution containing 1 μM of AF350-MLM 
and 1 mM DDT were measured with an excitation wavelength of 280 nm and 346 nm, 
respectively. When excited at 346 nm, the emission peak intensity at 440 nm was measured 
to be 6.6-fold of the peak intensity when excited at 280 nm. For AF350-MLM-labeled AcrB 
samples, emission spectra were collected at excitation wavelengths of 280 and 346 nm. 
The peak intensity observed at 440 nm, when excited at 346 nm, was used to back calculate 
the contribution from the direct excitation at 280 nm. This reference trace was subtracted 
from the FRET spectra.116 
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6.1.2 Results and discussion  
Measurement of FRET between tryptophan and AF350 
To design a FRET pair with minimum disruption to the structure of AcrB, I decided to take 
advantage of an intrinsic Trp to serve as the donor to form a FRET pair with Alexa Fluor 
350 (AF350) (Figure 6.1). Two Trp residues from neighboring subunits are close to each 
other at the inter-subunit interface, W13 and W895. To facilitate site-specific labeling, I 
first replaced the two intrinsic Cys from the sequence of AcrB with Ala and then introduced 
a W13C mutation. The triple mutant, CL-AcrBW13C, was fully active (data not shown). To 
create a negative control, I introduced an additional mutation, P223G, into the triple mutant 
to create CL-AcrBW13C/P223G. We have known from previous studies that the P223G 
mutation leads to trimer dissociation. We used CL-AcrBW13C/P223G as a “low affinity control” 
to compare with CL-AcrBW13C, which is our high affinity sample. Both CL-AcrBW13C and 
CL-AcrBW13C/P223G were purified and characterized using CD (Figure 6.1, A). The traces 
overlap with the spectrum of WT-AcrB, indicating the mutations did not cause protein 
unfolding. 
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Figure 6.1 A. CD spectra of WT (black), CL-AcrBW13C (red), and CL-AcrBW13C/P223G (blue) 
are very similar. B. Location of W13 and W895 from neighboring subunits. Trp can serve 
as a FRET donor to AF350.  
 
Purified CL-AcrBW13C and CL-AcrBW13C/P223G were labeled as described in materials and 
methods. After removing free dye using dialysis, UV/Vis spectra were used to determine 
the labelling efficiency of CL-AcrBW13C and CL-AcrBW13C/P223G using the molar ratio of 
AF350-MLM (346 nm) to AcrB (280 nm) (Figure 6.2). The labelling efficiency of CL-
AcrBW13C/P223G was close to 1.0, which was approximately twice of that of CL-AcrBW13C 
labeling. This difference is likely a result of the difference in intrinsic accessibility of C13, 
as C13 in CL-AcrBW13C is less accessible to AF350-MLM during labeling because of the 
higher trimer affinity. Then FRET between tryptophan and AF350 was measured using 
fluorescence spectrometer. The result shown in panel B confirmed the calculation of 
labelling efficiency. The ratio of FL430 (intensity at 430 nm) to FL340 (intensity at 340 
nm) reflected the degree of FRET. The value of ratio was 0.61 for CL-AcrBW13C and was 
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2.11 for CL-AcrBW13C/P223G.  
 
Figure 6.2 Spectroscopic analyses of AcrBW13C, AcrBW13C/P223G and their labelled products. 
A. UV/vis spectra of control and labeled samples. The peak intensity at 280 nm and 350 
nm was used to calculate the ratio of labeling. B. Fluorescence emission spectra of control 
and labeled samples. Excitation wavelength is 280 nm.   
 
To promote AcrB dissociation/unfolding, we titrated small aliquots of concentrated SDS 
into the samples (Figure 6.3 A). The traces are color coded to shift from red to blue with 
the increase in the SDS concentration. The intrinsic fluorescence of AcrB decreased 
drastically with the increase in the SDS concentration, presumably due to protein 
denaturation. The observed change of fluorescence was mainly contributed by Trp residues 
in the soluble domain.116 Monitoring the change of intrinsic fluorescence could reflect the 
process of AcrB gradually losing the folded periplasmic domain, which could be coupled 
with, or occur after, trimer dissociation. The peak at 340 nm was plotted against the 
concentration of SDS to reveal the protein unfolding profile (Figure 6.3, B). The unfolding 
profile of the labeled mutant proteins were very similar as the one we collected for wild-
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type AcrB, further confirming that the W13C mutation and the labeling did not have a large 
impact on the overall structure.  
 
 
Figure 6.3 A. Fluorescence emission of AF350 labeled CL-AcrBW13C (top) and CL-
AcrBW13C/P223G (bottom) when excited at 280 nm.  The traces are color coded to shift from 
red to blue with the increase of SDS concentration.  The two peaks at 345 and 430 nm 
corresponded to the intrinsic fluorescence emission of AcrB and emission from AF350, 
respectively.  Both decreased with the increase of SDS concentration.  B.  Normalized 
fluorescence intensity of CL-AcrBW13C at 345 nm (filled triangles) and 430 nm (open 
triangles), and CL-AcrBW13C/P223G at 345 nm (filled squares) and 430 nm (open squares).  
While the structure of CL-AcrBW13C/P223G began to unfold at a slightly lower SDS 
concentration than the structure of CL-AcrBW13C, the decrease of the FRET efficiency 
occurred as a much lower SDS concentration for CL-AcrBW13C/P223G. The lines are used to 
illustrate the trend of the data.  
Using the change of the intrinsic fluorescence as a beacon of AcrB dissociation/unfolding, 
researchers could evaluate the change of FRET efficiency during the process (Figure 6.3, 
B).  Since CL-AcrBW13C and CL-AcrBW13C/P223G were intrinsically labeled to different 
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levels, I normalized the AF350 signal changes using equation: (Y-Ymin)/(Ymax-Ymin), with 
the peak intensity in the absence of SDS designated as Ymax and the peak intensity at the 
highest SDS concentration designated as Ymin.  While the complexity of the system ruled 
out a numerical interpretation of the trimer affinity, it was clear that the FRET efficiency 
decreased more dramatically with the increase of SDS concentration for CL-AcrBW13C/P223G.                   
 
While working on the FRET experiment, I also had an unexpected discovery. Our lab has 
established through previous studies that freshly purified WT-AcrB exists predominantly 
as trimers. After prolonged incubation at 4oC in the time scale of days, trimer dissociation 
occurs and a monomer band can be observed in BN-PAGE analysis. The change is 
unidirectional. The intensity of the trimer band decreases over time, and the intensity of 
the monomer band grows. We have never observed a dimer band. For AcrBP223G, freshly 
purified sample is predominantly monomer. However, I found that after dialysis overnight, 
a large portion of AcrBP223G reassociated into trimers. The same is true for CL-
AcrBW13C/P223G (Figure 6.4). 
 
Next, I designed an experiment using FRET to monitor the trimer reassociation of CL-
AcrBW13C/P223G. The result showed that when low concentration of SDS was used to trigger 
trimer association (0.006% w/v), re-association of monomer could be observed when DDM 
was added (0.6% w/v) (Figure 6.4, C).  This result was consistent with Cui’s study on 
unfolding and refolding of AcrB.124 At this low concentration, AcrB unfolding has not 
occurred, as revealed by the lack of change of intrinsic fluorescence emission (Figure 6.4, 
B). AcrB trimer dissocaited when 0.006% (w/v) SDS was added and re-associated partly 
119 
 
when DDM was added to dilute the effect of SDS. It is critical to use this low SDS 
concentration, as AcrB unfolded at higher SDS concentration and could not reversibly 
refold under the current condition.  
 
In summary, FRET is a useful technique in studies of AcrB oligomer association. When 
SDS is titrated into a sample of AF350-labelled AcrBW13C or AcrBW13C/P223G, a change of 
FRET could be monitored at a SDS concentration lower than the concentration that triggers 
monomer unfolding. This dissociation of trimer is partly reversibly, and monomers re-
association could be observed when DDM is added to dilute SDS.  
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Figure 6.4 A. SDS-PAGE of purified AcrB samples. B. BN-PAGE analysis of the indicated 
AcrB samples. C. Fluorescence emission of AF350 labeled CL-AcrBW13C/P223G (black), in 
the presence of 0.006% (w/v) SDS (Blue) or 0.006% (w/v) SDS followed by 0.6% (w/v) 
DDM (red).   
 
6.2 How many copies of AcrB in one E.coli cell are enough to make the cell survive? 
To answer this question, the strategy is that the number of AcrB expressed from plasmid 
was controlled by dilution fold and the activity of relative diluted sample was determined 
through ethidium bromide accumulation assay. The protocol is following: the strain with 
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plasmid pBAD33-wt-acrB was cultured to OD600 of 1.0, and then diluted into fresh LB 
medium with different dilution folds. In the meantime, 0.2% glucose was added into the 
culture to inhibit AcrB synthesis. The diluted cells were re-cultured to OD600 of 0.6 to 0.8. 
Ethidium bromide accumulation assay was conducted to determine the activity of each 
sample.   To get an accurate result, some related questions need to be answered: 1) what is 
the Western blot detection limit for AcrB; 2) how many copies of AcrB could be expressed 
from plasmid; 3) is there leaky expression for AcrB even glucose was used to inhibit its 
synthesis. 
 
Western blot detection limit is determined as following: 
Freshly purified AcrB was diluted in different folds, then the diluted samples were analyzed 
by Western blot (Figure 6.5). When OD280 is 0.0002, molar concentration is 0.7 nM which 
was calculated by the equation following, the Western blot band is almost not visible, 
suggesting the detection limit.  
 c=A/(εl) = 0.0002 ÷ (89700 cm-1M-1×3×1 cm) = 0.7 nM 
And the mass is calculated by the quation:  
m=c*v*Mw = 0.7 nM ×16 μL × 113665×3 g/mol = 3.8 ng.  
 
Figure 6.5 Western blot analysis of purified WT-AcrB. 
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Using purified WT-AcrB as control, the amount of AcrB expressed from the plasmid 
pBAD33-wt-acrB was analyzed through Western blot (Figure 6.6). 2 mL of culture contains 
2*109 cells when OD600 is 1.0. For pBAD33-wt-acrB, 25-fold dilution is similar to WT-
AcrB with OD280 of 0.0002 in the standard. Therefore, there are 40 × 10-6 × 25 × 0.7 ×10-9 
× 6.02 × 1023 = 13244 × 108 copies of AcrB exist in the 2 mL cells. In each cell, there are 
13244 × 108 ÷ 2 ÷ 109 ≈ 220 copies of AcrB expressed from the plasmid.  
 
 
 
Figure 6.6 Determination of AcrB copy numbers expressed from the plasmid pBAD33-wt-
acrB which was named as “pWT-AcrB”.  
Glucose is always used to repress the expression mediated by the PBAD promoter of araBAD 
(arabinose) operon.184 In the study, 0.2% glucose was added into the culture to repress AcrB 
expression. Comparing Western blot result to ethidium bromide accumulation result, the 
cells could still survive after 100,000 dilutions (Figure 6.7) which was not expected. One 
possible explanation is that the inhibition effect of glucose is incomplete, and thus some 
AcrB are still expressed, although it cannot be detected by Western blot.  
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Figure 6.7 Western blot analysis of diluted pWT-AcrB. 
 
Ethidium bromide accumulation assay was conducted as the protocol described in the 
previous chapter. The result showed that even for the sample diluted in 100,000 folds, the 
cells are still active, suggesting that the number of AcrB in the cells is enough for pumping 
out ethidium bromide dye.  
 
Figure 6.8 Ethidium bromide accumulation assay of diluted samples. WT-0, 1, 2, 3, and 4 
represents the dilution folds of 5, 25, 500, 12500, 100000, respectively. The strain ΔacrB 
was used as negative control.  
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Leaky expression of glucose inhibited pWT-AcrB was determined through Western blot 
and purified WT-AcrB was used as a control. As shown in Figure 6.9, band intensity 
analyzed through Image J for the sample “Gi-WT 0×” is 717, while it is 1442 for “WT-
AcrB 25×”. The ratio is 717 ÷ 1442 = 0.4972. So, the leaky expression is about: 0.00111 
×10-6 mol/L × 40 ×10-6 L × 6.022×1023 ÷ (2 mL ×1×109/mL) ≈ 13 copies for each cell, 
indicating that the cells with about 13 copies of AcrB could survive. The exact copy 
number is possibly smaller than 13, but it could not be determined through traditional 
biochemistry techniques such as Western blot. More advanced method need to be applied 
to determine the exact number.  
 
 
Figure 6.9 Leaky expression level determination of glucose inhibited WT-AcrB (Gi-WT-
AcrB). 
 
6.3 Expression and purification of Hepatitis B virus core protein CP149. 
6.3.1 Materials and Methods 
The gene encoding CP149 was cloned into vector pET24a for expression without any tag 
and the sequence was confirmed via DNA sequencing. The plasmid pET24a-CP149 was 
then transformed into BL21(DE3) strain for protein expression. A single colony was used 
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to inoculate 10 mL of LB media supplemented with 50 ug/mL kanamycin (kan). The culture 
was incubated with shaking at 250 rpm overnight at 37 oC. The next morning, the overnight 
culture was diluted into 1 L fresh LB/kan media. The culture was incubated at 37 oC with 
shaking at 250 rpm until the OD600 reached 0.8, and then Isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to a final concentration of 2 mM to induce the 
expression of CP149. After an additional incubation of 5 hours, cells were collected by 
centrifugation at 7000×g for 10 minutes. The cell pellet was stored at -80 oC until 
purification. Purification was conducted following published procedure.185 Briefly, cells 
were resuspended in a buffer containing 50 mM Tris-HCl (pH 7.4), 1 mM EDTA, 5 mM 
DTT, 0.01 mg/mL RNase, and 2U/mL DNase. The cells were lysed by sonication in 
ice/water bath and centrifuged to collect the supernatant. Solid sucrose was added to the 
supernatant to a concentration of 0.15 M followed by centrifugation. Solid (NH4)2SO4 was 
added to the supernatant to a final concentration of 40% saturation. The solution was 
incubated with gentle stirring at room temperature for 1 hour and then centrifuged again to 
collect the pellet. The pellet was resuspended in a buffer containing 100 mM Tris-HCl (pH 
7.5), 100 mM NaCl, 50 mM sucrose, and 2 mM DTT (buffer A) and loaded on a Sephadex 
G-100 column equilibrated with the same buffer. Fractions were analyzed using SDS-
PAGE. The fractions with high concentration of CP149 were combined and concentrated 
into 25 mL through Amicon® Ultra-15 (EMD Millipore Corporation, Darmstadt, 
Germany). Solid urea was added into concentrated sample to a final concentration of 3 M. 
EDTA was added into the solution to a final concentrationo of 1 mM. After incubated for 
3 hours on ice, the sample solution was loaded onto a Sephadex G-100 column. The 
fractions were collected after elution with Buffer A and analyzed using SDS-PAGE. The 
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fractions containing dimers with high purity were collected and concentrated using 
Amicon® Ultra-15. 
 
 
 
 
 
 
 
6.3.2 Results 
The following pictures showed the analysis result of each step in purification.  
 
Figure 6.10 Chromatography profile as monitored using absorbance at 280 nm. 
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Figure 6.11 SDS-PAGE analysis of fractions. The major band close to 17 kD is CP149 
monomer.  
 
Then frations 7 to 12 were combined and concentrated using ultrafiltration with a 
Centricon-10 (Amicon). Urea and EDTA were added to final concentrations of 3 M and 1 
mM, respectively, and the sample was incubated on ice for 3 hours. The treated sample was 
loaded and analyzed using the Sephadex G-100 column again. Fractions were analyzed by 
UV-VIS and SDS-PAGE.  
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Figure 6.12 Chromatography profile as monitored using absorbance at 280 nm after treated 
with urea and EDTA. 
 
Fractions with high purity was combined and concentrated through Amicon. SDS-PAGE 
was used to analyze the purity. The gel showed that the purity of CP149 is more than 90% 
and most of them are dimers, even the samples were treated with 2 mM DTT.  
 
 
Figure 6.13 Purified CP149 treated DTT and CP149 control.  
 
 
Figure 6.14 UV wavelength scan of purified CP149. 
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Analysis of purified samples. 
CD and fluorescence analyses of purified Cp149. Fraction 14 was used for these analyses.   
CD spectrum revealed two negative peaks at 208/222 nm, consistent with the overall 
helical structure of CP149. 
 
Figure 6.15 CD analysis of purified CP149 sample. 
 
Fluroescence spectra 
Wavelength scan was conducted at following condition: exicted at 280nm, ex slit 10nm, 
em slit 4nm, scan from 290nm to 400nm. The emission peak is at 342nm. Clearly, emission 
at 342nm for CP149 treated with 0.8M KCl is stronger than that for Cp149 alone, which 
could be due to assembly of CP149.  
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Figure 6.16 Fluorescence analysis of purified CP149 and purified CP149 treated with 0.8 
M KCl. 
6.4 Degradation of ssrA-tagged membrane protein by ClpXP 
6.4.1 Degradation of AcrB-cI-ssrA by ClpXP 
Lambda repressor protein cI is a transcriptional repressor that allows virus to establish and 
maintain latency which prevents both the viral DNA replication and the exit programs. 
Inserted as a linker between AcrB and ssrA tag, cI was used to determine whether it 
facilitated the degradation. AcrB-cI-ssrA was expressed well in clpX knock-out strain while 
it was not in the strain containing clpX.  To clarify the degradation occurred after the protein 
was inserted in the membrane, the plasmid pBAD33-acrB-cI-ssrA was co-transformed into 
pET28a-clpX. Biosynthesis of ClpX was induced with 1.0 mM IPTG when OD600 reached 
1.0, and then degradation of AcrB-cI-ssrA started. All the substrates were degraded in 80 
minutes, indicating that the degradation occurred after the insertion of AcrB-cI-ssrA to 
membrane.  
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Figure 6.17 Expression level determination of AcrB-cI-ssrA in competent cells with or 
without clpX gene. 
 
Figure 6.18 Co-expression of AcrB-cI-ssrA and ClpX. 
 
To confirm AcrB-cI-ssrA was degraded by ClpXP system, freshly purified AcrB-cI-ssrA 
was mixed with purified ClpX, ClpP and SspB in PD buffer containing 5mM ATP and ATP 
regeneration system.  Over 60% of the substrate degraded in 10 minutes which had similar 
degradation rate with AcrB-CFP-ssrA and GFP-ssrA.  
 
 
Figure 6.19 Degradation of AcrB-cI-ssrA in vitro. A. The degradation was shown through 
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Western blot. B. The degradation was shown in loss percentage which was obtained 
through calculation of band intensities.  
 
6.4.2 Degradation of other ssrA tagged membrane protein.  
To investigate whether other ssrA tagged membrane proteins were degraded by ClpXP, 
YajC-ssrA was expressed and purified. Freshly purified YajC-ssrA was mixed with ClpXP 
system, and it was completely degraded in 6 minutes which was much faster than that of 
AcrB-CFP-ssrA and AcrB-cI-ssrA (Figure 6.20).  
 
Figure 6.20 Degradation of YajC-ssrA in vitro.  
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